Subject Index for Volume 51

Subject Index for Volume 51 A Aborigines, Australian, renal disease in (abst) Acetate blood level changes with HD (abst) Acid-base balance AE1 and H-ATPase in acidosis/alkalosis cerebral edema, after treatment of DKA maintenance HD and (abst) transporters, ischemic-reperfusion injury Acidosis. See also Metabolic acidosis

distal renal tubular, absence of H-ATPase (abst) uremic/non-uremic, GH, IGF-1 Activin-like receptor kinase-5, TGF-pl, developing metanephros (abst) Acute renal failure (ARF) acute pyelonephritis, clinical characteristics (abst) arsine gas exposure, CVVHD (abst) due to building collapse (abst)

1318 953 125 1237 953 1106

948 58:S-102 1310

myoglobin cytotoxicity

(abst) prerenal azotemia in elderly (abst) renal function in elderly Albumin glycated, modulates NO production

Alkalosis, metabolic, AE1 regulation and H-ATPase in.. 125 Allografts. See also Rejection 310 early protocol biopsy, graft outcome and 962 early routine biopsies, histopathology in (abst) 58:S-15 intrarenal gene expression during rejection 966 Allopurinol, ischemia-reperfusion injury, rats (abst) a-subunit of neutrophil NADPH oxidase, in kidney and liver

966 1317 966 1463 728 1956

ischemic, leukocytes, cell adhesion molecules and

myoglobinuric, pathogenesis of renal cell injury, nature of Adhesion molecules attenuation of ischemic ARF expression in Shwartzmari reaction, rabbit (abst) in glomerular mesangium integrin cytoplasmic domain modulates cell proliferation integrin-ligand interactions integrins, laminins in tissue remodeling integrins and tumor therapy receptors, role in nephritis receptors in development and remodeling rejection of renal allografts selectin ligands, leukocytes and Fuc-TVII Adrenal tumor, hypokalemia, hypertension, dissecting aneurysm (abst) Adult respiratory distress syndrome, arsine gas exposure, CVVHD (abst) Advanced glycation end-products (AGEs) 2-m interaction, dialysis-related amyloidosis binding, AGE receptor in diabetic rat kidney (abst) . . imidazolone modifies amyloid /32m oxidative stress, ESRD pentosidine clearance in RRT Advanced glycosylation end-products (AGEs) pathogenic role in diabetic nephropathy (abst) pathophysiologic role in CAPD AE1 regulation and H-ATPase in acidosis/alkalosis African Americans linkage analysis of cytokines in ESRD Study of Kidney Disease (AASK) Trial Age. See also Children CAPD outcome comparison, older/younger patients

1053 high glomerular permeability of bikunin 958 infusion, serum Lp(a) concentration, CAPD (abst) serum, as CAPD morbidity/mortality predictor (abst).. . 959 1326 serum, urea reduction ratios, HD patients (abst) Albuminuria, low birth weight, RF in Australian 1318 Aborigines (abst)

1341 1463

949 1447 1434 1454

Amyloidosis

1441 1413

1469 1427 1476 1418

945

1317 1514 .

1314

187 1170 880

947 182 125

819 244 957 965 1196

dialysis-related, 2-m binding to collagen-AGE dialysis-related, 2-m histological prevalence in dialysis-related, imidazolone modifies j32m

1514 1928 187 1663

Andreoli, Thomas E Anemia EPO therapy, in CRF 622 glomerular dysfunction in sickle cell 826 945 rHuEPO effect 5/6 nephrectomized rat (abst) Anesthesia, surgery, and nitric oxide 1943 Aneurysm, dissecting, hypokalemia, hypertension with adrenal tumor (abst) 945 Angiotensin-converting enzyme (ACE) chronic diuresis and renal tubular cells 36 gene polymorphism, cardiac changes post-transplant. . . 1205 gene polymorphism, childhood reflux nephropathy 950 (abst) gene polymorphism in NIDDM nephropathy (abst) . .. . 946 119 genotypes and diabetic hyperfiltration inhibitors, aspirin, dipyridamol therapy in IgAN (abst). . 969 Angiotensin II (Ang II) alters [Ca]i in MC of diabetic rats 87 induces PAT-i in MC 664 44 intraluminal, RPP, acute volume expansion L-arginine in tissue fibrosis 1481 164 PAl-i modulation, endothelial injury synthesis/metabolism changes with Na loading (abst) . . 1309 1553 TGF-131, post-subtotal nephrectomy Anion exchanger AE1 regulation and H-ATPase in acidosis/alkalosis

27

479

a1-adrenergic receptor, mRNA expression, rat nephron . 1548 Alport syndrome bull terrier hereditary nephritis as model (abst) 1320 COL4A5 mutation screening method (abst) 1324 1493 gene therapy 58:S-69 pathobiology, genetics of 961 transplantation prognosis (abst) Amadori adducts of glycated albumin and NOS activity.... 27 Amino acids plasma concentrations, ESRD, Koreans and 954 Americans compared (abst) uremic muscle metabolism 1182 1309 Amylin renal binding correlated with BP, rat (abst)

Antenatal hydronephrosis due to UPJ obstruction (abst) ..

2097

125 951

2098

Subject Index: VoL 51

Anti-angiogenic TNP-470 inhibits MC proliferation Anti-glomerular basement membrane nephritis anti-IFNy inhibits crescent formation and cutaneous DTH (abst)

1838

1319 1809 1313

IL-b treatment in rats

Arterial hypertension, renal consequences of, 1639 Nephrology Forum Arteriosclerosis in CRF 1678 Arteriovenous fistula (AVF) closure, anaerobic threshold, cardiac output (abst) . . . . 1321

1327 Thoratec macrophage migration inhibitory factor (abst) 104 As4.1 cell line and prorenin activation 222 susceptibility to, HLA-DRB1 genes and Aspirin, dipyridamol, ACEi therapy in IgA nephropathy Anti-interferony antibody inhibits cutaneous DTH, 969 (abst) 1319 crescent formation in anti-GBM UN (abst) Atherosclerosis Anti-platelet antibodies, heparin-induced in chronic renal failure 1678 952 thrombocytopenia (abst) 958 CV disease, lipoprotein(a), CAPD (abst) Anti-Thy-i antibodies, induce apoptosis of rat MC 173 2037 Atkins, Robert C Anti-Thy-I nephritis, TGF-/31 and PDGF /3 in mice 967 Atrial natriuretic peptide (ANP) (abst) acute/chronic volume expansion, natriuresis (abst) . . . . 1307 Anti-thymocyte antibody-induced UN, MCP-1, mRNA in diabetic rat kidney 1100 770 monocyte/macrophage influx 59:S-28 physiologic role and diuretic efficacy Antibiotics, catheter-related sepsis without catheter 281 receptors in human CCD cell line 945 removal (abst) Australian Aborigines, renal disease in (abst) 1318 Antibodies 1739 Autoimmunity agonistic anti-Fas, glomerular apoptosis Fas and ICE in CrmA transgenic and lpr mice (abst) . . 1321 anti-IFNy inhibits crescent formation and cutaneous genetic susceptibility to anti-GBM disease 222 1319 DTH (abst) IL-12 in tubular epithelium of MRL-Fas" mice 79 672 antibody independent crescentic UN 1583 lupus, mycophenolate mofetil limits renal damage dimeric monoclonal IgA anti-Thy-i, apoptosis of MC.. . 173 Autosomal dominant polycystic kidney disease (ADPKD) GN, crescent formation in p. chain deficient mice 353 complications of, Nephrology Forum 1319 (abst) 2022 extrarenal manifestations, Nephrology Forum porcine xenoantigen Gala(i,3) Gal eliminated (abst) . 1324 sex hormones and fluid secretion in MDCK cells 1535 porcine xenoantigen Gala(i,3) Gal in transgenic mice Axial skeletal BMD changes, post-parathyroidectomy 1323 1308 (abst) (abst) 1608 Anticardiolipin antibody (ACA), lupus anticoagulant in Azathioprine, CsA and lipid peroxidation vascular access occlusion (abst) 952 Azotemia 1160 in PKD rats Anticoagulation. See Heparin Antidiuretic hormones, VP and oxytocin function as 965 prerenal, clinical characteristics in elderly (abst) 949 (abst) Antigens HLA system, antigen processing and presentation.... 58:S-2 B porcine xenoantigen Gak(i,3) Gal eliminated (abst) . 1324 B-cell selection and apoptosis in the germinal center 1321 (abst) porcine xenoantigen Galn(i,3) Gal in transgenic mice 507 Baker's yeast (Saccharomyces cerevisiae), hypoxia in 1323 (abst) Basal serum biochemical markers of survival, HD (abst) . . 956 Antihypertensive therapy 1596 diet and diabetes 58:S-66 Benign familial hematuria, thin GBM nephropathy /32-microglobulin (/32-m) ECM, mononuclear cells in UNX SHR 750 1928 amyloid, histological prevalence in HD short-term, GFR and stability of renal function 793 187 amyloid, modified with imidazolone, dialysis Antioxidants 1514 binding to collagen-AGE in DRA dietary, inhibits lipoprotein oxidation in FSGS 1151 vitamins and EPO production 497 Bicarbonate concurrent salbutamol, acute therapy of hyperkalemia 1323 Apical Na-H exchange, IGF-1, human PTC (abst) 957 (abst) Apoptosis muscle mass in metabolic acidosis (abst) 948 962 acute rejection, clinicopathology (abst) 1053 Bikunin, high glomerular permeability agonistic anti-Fas antibodies induce glomerular 1739 Bioelectrical impedance, LBM derived from, in ESRD, B-cell selection, in the germinal center (abst) 1321 955 HD (abst) developing renal corpuscles, prenatal rat kidney (abst) . . 967 Bioimpedance spectroscopy, postural changes, volume Fas, ICE and autoimmunity, CrmA transgenic and lpr estimation 1078 1321 mice (abst) Biopsy, renal induced in rat GMC by anti-Thy-i antibodies 173 1310 11J3HSG2 findings in renal disease (abst) ionizing radiation, cytotoxic drugs induce in MC (abst). . 968 absence of H-ATPase in distal renal tubular acidosis mesothelial cells, PD solution induces 1280 948 (abst) pyelonephritis provokes, in infant rat renal cortex 1855 962 allograft histopathology in recipients (abst) 1312 TIN, resolution of experimental (abst) 310 early protocol allograft, graft outcome and 964 tubulointerstitial nephritis (abst) 1311 expression of multiple cytokines, human (abst) 968 verapamil effect in CsA nephrotoxicity (abst) 968 manual and automated, comparative study (abst) 969 Arg-Gly-Asp (RGD peptides) as therapeutics in acute percutaneous, complications after 1487 Biopty gun, percutaneous kidney biopsy (abst) renal injury 1316 Arsine gas exposure, management with CVVHD (abst) . . 1317 Biostat urea monitor .

.

2099

Subject Index: Vol. 51

evaluates solute clearance, dialysis adequacy (abst). . . . 1330 evaluation of (abst) 1329 Blood lipids and PAl-i in CsA nephropathy 1818 Blood pressure Ang II and L-arginine in tissue fibrosis 1481 954 central response to ROS, CRF (abst) 1212 hypoalbuminemia, HD low Ca dialysate, Ca metabolism, CAPD (abst) 1328 1863 nycthemeral pattern in treated hypertension, HD Blood transfusion during heparin-free HD 2018 Bone disease Ca handling in ovariectomized rat 1719 Ca stone risk factors, post-transplant 804 fractures, vitamin K and iPTH 1218 1590 parathyroid Ca sensing 956 predialysis patients in Korea (abst) 1329 site specific risk factors, dialysis (abst) steroid-induced, frequently relapsing childhood 965 MCNS, la(OH)-vitamin D3 (abst) Bone mineral density (BMD) axial skeletal changes, post-parathyroidectomy (abst) . . 1308 i.v. calcitriol effect, SHPTH, chronic HD (abst) 955 1329 pitfalls of DXA in dialysis (abst) Brain 59:S-69 edema, pathogenesis and therapy 416 intrinsic erythropoietin production 372 oxygen pressure in Brain natriuretic peptide (BNP) 1308 ouabain, effects in saline-loaded sheep (abst) 950 release, body fluid balance (abst) 59:S-76 Breast cancer, postmastectomy edema Brush border membrane (BBM) vesicles, cadmium effect on Na-Pi transport, rabbits (abst) 949 Bull terrier hereditary nephritis as model for Alport 1320 syndrome (abst) C

C-type natriuretic peptide (CNP) receptors in human CCD cell line C3 activated, and IgA nephropathy

281 1257

gene expression, TNF-a regulates in endothelial cells. . . 703 receptors, cultured rat glomerular endothelial cells. . . . 1124 C6, extrahepatic/hepatic, generation of renal C5b-9 1788 CA125 in peritoneal effluent 888 Cadmium effect in Na-Pi transport, rabbit BBM vesicles 949 (abst) Calciphylaxis in renal failure (abst) 1315 Calcitonin effect on calcium transport 1999 Calcitriol i.v. effect on SHPTH and BMD, chronic HD (abst) .... 955 tubular Ca reabsorption in CRF (abst) 1308 Calcium -induced mitochondrial swelling by CsA (abst)

964

cytosolic, Ang II and norepinephrine, MC of diabetic rats 87 cytosolic, hypoxia and tyrosine hydroxylase gene 536 expression handling in ovariectomized rat 1719 728 intracellular, myoglobin cytotoxicity in PT cells intracellular, PTC elevation, PTH-PTHrP, Via, AT1 receptors in diabetes 1950 1328 metabolism, low Ca dialysate, BP, CAPD (abst) pump inhibitors in uremic plasma 1042 reabsorption, defective in genetic hypercalciuric rats. . . 1540

1308 reabsorption in CRF, calcitriol (abst) receptor, parathyroid expression in 328 hyperparathyroidism salt urolithiasis, thermodynamic equilibrium model 1315 (abst) sensing in renal osteodystrophy, PTH and 1590 1999 transport, calcitonin effect on 967 urinary excretion, children with UTI (abst) Calcium channel blockers skeletal muscle metabolism (abst) 1306 968 verapamil, apoptosis in CsA nephrotoxicity (abst) verapamil, morphology and CsA nephrotoxicity (abst) . . 965 Calcium oxalate 679 monohydrate crystals, renal cell OPN release 804 urinary supersaturation, post-transplant Calculi Ca salt urolithiasis, thermodynamic equilibrium model 1315 (abst) Ca stone risk factors, post-transplant 804 640 crystal inhibition in rats defective calcium reabsorption 1540 894 supersaturation and stone composition Cameron, J. Stewart 2060 Cancer 59:S-76 postmastectomy edema 946 thyroid, overlap type of polyarteritis nodosa (abst) tumor markers in CRF (abst) 954 1069 Carbachol, renal Na-HCO3 cotransporter Carbohydrate metabolism, role of oxygen in zonation of . . 402 Cardiovascular disease atherosclerosis and arteriosclerosis in CRF 1678 958 atherosclerotic, Lp(a), CAPD (abst) BP variability in ESRD 1863 heart failure, diuretic-resistant edema in 59:S-66 heart failure, hemofiltration in severe 59:S-62 heart failure, water and Na retention in 59:S-57 1322 hypercholesterolemia and transplantation (abst) 1205 LVH post-transplant 1322 screening elderly transplant recipients for (abst) Cardiovascular function As4.1 cell line and prorenin activation 104 cardiac output and AVF closure (abst) 1321 renal function in the elderly 1196 Carnitine deficiency, skeletal muscle metabolism, CRF 1309 (abst) Catheters. See Vascular access CD8 T-cell depletion, proteinuria, Heymann nephritis 1325 (abst) CD28:B7 costimulatory interaction, alloimmune 58:S-8 responses CD4O-induced chemokine production by hPTEC 711 Cell death in hypoxia and tyrosine phosphorylation 1747 Cell proliferation modulated by integrin cytoplasmic domain 1434 Cellular immunity, determinants of susceptibility to ON. . 646 467 Central neurons, sensing oxygen deprivation in Cerebral edema after treatment of DKA 1237 Chemokines 770 anti-Thy antibody-induced ON, MCP-1 711 CD4O-induced production by hPTEC MCP-1 pathogenesis in cryoglobulinemic GN 153 1754 regulation by IL-6-like cytokines renal disease and 610 Chemotherapeutic cisplatin, reversible multiorgan failure 948 with (abst) .

2100

Subject Index: Vol. 51

Children. See also North American Pediatric Renal Transplant Cooperative Study ACE gene polymorphism in reflux nephropathy (abst) . . 950 1322 born to transplant recipient mothers (abst) 1326 CVVH and CVVHD in critically ill (abst) 59:S-100 edema in 1313 enhanced LDL uptake, nephrosis (abst) frequently relapsing MCNS, 1 a(OH)-vitamin D3, 965 osteoporosis (abst) 1970 growth factors in CRF 777 LH receptor inhibitors in boys with CRF 58:S-114 long-term rhGH in CR! 970 membranous GN, clinical studies (abst) PermCath HD access catheters (abst) 952 1305 renal outcome one-year after UT! (abst) TGBM disease without glomerular IgA deposits (abst).. 969 1318 UT!, Australian Aborigines (abst) VUR therapy prevents ESRD from reflux nephropathy 1306 (abst) Chinese medicine, NEP monitors PT injury, herbal 288 nephropathy Chloride channel blockers, cytoprotective effects in hypoxia

Chloride channels, volume regulation and

Chlorothiazide alters Mg2 transport in DCT Cholesterol, blood lipids and PAl-i in CsA

1529 477 1008

1818 nephrotoxicity Cholinergics, carbachol and renal Na-HCO3 1069 cotransporter Chronic renal failure (CRF) 1678 atherosclerosis and arteriosclerosis in 954 central pressor response to ROS (abst) 59:S-33 diuretic therapy in 622 EPO therapy of anemia in 840 extended IGF-1 use 58:S-106 GH/IGF axis, derangements in growth factors in children 1970 immature reticulocytes indicate erythropoiesis (abst) . . . 953 946 isolated C3 mesangial proliferative GN (abst) 777 LH receptor inhibitors in boys 965 NS pathologic types, protein C and S (abst) renal nerves and hypertension 722 skeletal muscle metabolism, propionyl L-caritine (abst). 1309 tubular Ca reabsorption, calcitriol (abst) 1308 954 tumor markers in (abst) Chronic renal insufficiency (CR1), long-term rhGH in 58:S-114 children Ciprofloxacin, gentamicin, compared in acute 1316 pyelonephritis (abst) Cirrhosis, water and Na retention in 59:S-43 Cisplatin-based chemotherapy, reversible multiorgan 948 failure with (abst) Cobalt chloride 483 oxygen sensing pathways in HepG2 cells ROS and EPO production 492 COL4A5 mutation screening method, Alport syndrome 1324 (abst) Collagen III myofibroblast and a1(I!I) expression in TIN. . 926 Collagen IV synthesis and endothelial cell proliferation 964 (abst) Complement activated C3 and IgAN 1257 C3 receptors, cultured rat glomerular endothelial cells . 1124 extrahepatic C6 and renal C5b-9 1788 703 synthesis by endothelial cells

Congenital nephrotic syndrome, Finnish type, DNAbased diagnosis Connective tissue, PDGF as regulator in embryogenesis, pathogenesis Continuous ambulatory peritoneal dialysis (CAPD) AGE peritoneal accumulation/detection albumin infusion, serum Lp(a) concentration (abst) . . atherosclerotic CV disease, Lp(a) (abst) clinical outcome predictors (abst) connector systems compared, peritonitis and (abst) disconnect/discard system assessment (abst) exit-site infection, surgical management (abst) fluid transfer systems compared (abst) fusidic acid concentrations in dialysate (abst) gastric emptying time (abst) human peritoneal fibroblast in 3D culture IGF-1 and nutritional status (abst) laparoscopic Tenckhoff catheter insertion (abst) lean body mass measurements compared (abst) low Ca dialysate, Ca metabolism, BP (abst) nitroprusside and peritoneal permeability outcome comparison, older/younger patients (abst) peritoneal membrane transport, nutritional status (abst) risk factors for hypercalcemia (abst) serum albumin as morbidity/mortality predictor (abst) . serum Lp(a), apolipoprotein(A) (abst) surgical aspects of PD (CAPD) access (abst) Continuous veno-veno hemodialysis (CVVHD) arsine gas exposure, ARF (abst) in critically ill children (abst) Continuous veno-venous hemofiltration (CVVH) in critically ill children (abst) Contrast media effects in acute ureteral obstruction Cortical collecting ducts (CCD) natriuretic peptide receptors in human cell line sodium nitroprusside, effects in rats Creatinine clearance, as index of nutritional status (abst) fingernail concentration, as RF marker (abst) generation rate and LBM, in PD serum, ESRD prognostic significance Crescent formation, anti-IFNy inhibits cutaneous DTH, anti-GBM GN (abst) Crescentic glomerulonephritis antibody independent fibrin dependent, T-cells, tissue factor pathway inhibitor (abst) .

IL-b treatment in rats

868 1361

182 .

958

958 959 960 1327 960 1329 1328 957 205

960 1328 959 1328 1885 957 958 959 .

959

958 1328 1317 1326 1326 653 281

473 954 1317 855 850 1319

672 1320 1809

SK&F105685 suppresses cutaneous DTH, rats (abst) . . 1325 94 Thi cells direct crescent formation, mice tissue factor inhibition, renal injury, fibrin deposits 1310 (abst) tissue factor pathway inhibitor, fibrin deposits (abst). . . 1313 1325 TNF-c, IL-i blocking, rats (abst) 966 Crush syndrome, ARF due to (abst) Cryoglobulinemic membranoproliferative GN, 153 pathogenetic role of MCP-1 Cyclic adenosine monophosphate (cAMP) 564 -responsive HIF-1 DNA recognition site hepatorenal link, proximal reabsorption, renal 59:S-50 hemodynamics 1500 Cyclic ADP-ribose metabolism in glomeruli 1088 Cyclin kinase inhibitor determines MC proliferation Cyclins

Subject Index: Vol. 51

1228 E-cdk 2 activation, MC cycle control by TGF-f31 762 expression during renal development Cyclophosphamide therapy, lupus nephritis, renal survival in black Americans 1188 Cyclosporine (CsA) -induced remission of relapsing MCNS (abst) 946 cellular proliferation during compensatory renal 965 growth (abst) 1608 lipid peroxidation, post-transplant steroid-resistant idiopathic NS 58:S-85 Cyclosporine (C5A) nephrotoxicity blood lipids and PAT-i in 1818 inhibition of Ca-induced mitochondrial swelling in 964 kidney (abst) 965 verapamil, morphologic effect of (abst) 968 verapamil effect on apoptosis (abst) 1893 Cystinuria and SLC3A1 mutation 479 Cytochrome b58 and oxygen sensing Cytochrome P450-derived renal HETEs 1696 Cytokines 1352 action, importance of context in biology of TGF-f3, knockout and transgenic mouse models 1355 expression of multiple, human renal biopsies (abst). . . . 1311 gelatinase A and MC growth 1397 human peritoneal fibroblast in 3D culture 205 1754 IL-6, LIF, oncostatin, regulate chemokines 1401 immune injury, TGF-J3 and endothelial cells immunosuppressive drug comparisons on mRNA 1320 profiles, human MLC (abst) 819 linkage analysis and ESRD macrophage migration inhibitory factor, anti-GBM ON 1313 (abst) PDGF and connective tissue 1361 1520 regulate LTB4 synthesis in monocytes 1383 regulation of vascular morphogenesis by SPARC schistosome-induced granuloma and fibrosis 1370 1376 TGF-13, activation of latent 1388 TGF-13 in kidney fibrosis, gene therapy target Cytomegalovirus (CMV) 961 detection in transplant recipients (abst) 961 gancyclovir, optimal indication of treatment (abst)

Cytotoxicity

drugs, ionizing radiation induce MC apoptosis (abst) . . 968 1059 in glomeruli, T-cells in Heymann nephritis myoglobin, in PT cells 728 860 pyruvate dialysate and PD toxicity .

D

Decorin expression in hydronephrosis Delayed-type hypersensitivity antibody independent GN, crescent formation in jx chain deficient mice (abst) cutaneous, anti-IFNy inhibits crescent formation, anti-

GBMGN(abst)

1133 1319 1319

cutaneous, crescentic ON, suppressed by SK&F105685, 1325 rats (abst) Denys-Drash syndrome, WT1 gene mutation, molecular 949 genetic study (abst) Desferrioxamine 483 oxygen sensing pathways in HepG2 cells ROS and EPO production 492 Diabetes ANP mRNA in rat kidneys 1100

[Ca2j, PTH, Vla, AT1 receptors in

1950

2101

1797 mesangial cell actin disassembly Diabetes mellitus (DM) 811 intrarenal IGF-1, regional changes in oxidant stress in kidney (abst) 1314 963 post-transplant (abst) 1602 type II, hereditary factors in 1920 type II, intrarenal vascular resistance Diabetic ketoacidosis, cerebral edema after treatment of . 1237 Diabetic nephropathy (DN) 119 ACE gene polymorphism, renal hemodynamics 946 ACE gene polymorphism in NIDDM (abst) AGE binding, quantitation and receptor, rat kidney 1314 (abst) 947 AGE pathogenic role (abst) AGE pathophysiologic role in CAPD 182 87 [Cali, Ang II, norepinephrine in rat MC elevated plasma total renin precedes microalbuminuria 1309 (abst) 27 glycated albumin modulates NO production hereditary factors in type II diabetes 1602 intrarenal hemodynamic abnormalities measured 1920 lipoprotein metabolism, antioxidants, IDDM (abst). . . . 1305 1624 morphometric analysis of mesangium 50 MRI and kidney morphology myofibroblasts correlate with fibrotic markers (abst). . . 1314 57 pathogenesis, glomerular mechanical strain in 1309 perindopril, enalapril compared (abst) 947 progression, glucose control and (abst) 58:S-66 proteinuric progressive, renal ET "What doctors don't know about kidneys," by Senator 1340 Jake Garn Dialysate dialyzer urea mass transfer-area coefficients 2013 1328 low Ca, BP, Ca metabolism in CAPD (abst) PD, induces mesothelial cell apoptosis 1280 PD solutions with thiol compounds, glucose 1330 degradation (abst) 860 pyruvate, PD toxicity and

Dialysis

59:S-39 chronic HD, dryness, and fluid overload 955 diet and metabolic acidosis (abst) 981 HCV infection 834 increased reticulated platelets 1329 osteopenia, site specific risk factors (abst) 1330 peracetic acid dialyzer re-use program (abst) post-dialysis urea concentration, estimation of 2000 equilibrated 2013 Dialyzer urea mass transfer-area coefficients Diet antihypertensives and diabetes 58:S-66 antioxidants inhibit lipoprotein oxidation in FSGS .... 1151 low protein, metabolism in uremia 1222 955 metabolic acidosis in chronic dialysis (abst) Modification of Diet in Renal Disease Study Group. .. 1908 Dioxin-regulated gene expression, mouse hepatoma cells. . 567 Dipyridamol, aspirin, ACEi therapy in IgA nephropathy 969 (abst) Distal convoluted tubule cells

phosphate depletion and Mg2 uptake in mouse DCT. 1710 1008 thiazides alter Mg2 transport Distal renal tubular acidosis, absence of H -ATPase on biopsy (abst) Diuretics -resistant edema in heart failure adverse reactions of

948 59:S-66 59:S-16

2102

Subject Index: VoL 51

loop, ACE, chronic diuresis and renal tubular cells 36 59:S-1 I mechanism of action, renal transport and 1008 thiazides alter Mg2 transport in DCT 1018 thiazides correct SHR hypercalciuria 59:S-33 use in chronic renal failure use in hypertensives 59:S-36 DMSA renal scan, acute pyelonephritis, adults (abst). . . . 1319 DNA 868 -based diagnosis, congenital NS, Finnish type 1747 damage, tyrosine phosphorylation in hypoxia 564 HIF-1 recognition site is cAMP responsive library screening, changing patterns of gene expression. . 920 representational difference analysis, gene eDNA in 1629 embryonic kidney DOCA-salt hypertensive rats, isolated kidney function 1307 (abst) Donor kidneys 962 age/sex and graft survival rates (abst) 961 cadaveric, donor factors, early graft function (abst) 961 living related, flow cytometry crossmatch (abst) Doppler sonography duplex, measures intrarenal hemodynamic abnormalities in DN 1920 evaluates percutaneous renal biopsy complications 969 (abst) Dual energy x-ray ahsorptiometiy (DXA) pitfalls in dialysis (abst)

E

1329

Early growth response gene-i (Egr-l), MC proliferation . . 694 310 Early protocol renal allograft biopsies Ecto-5'-nucleotidase in kidney and liver 479 Edema ANP effects in healthy and renal subjects 59:S-28 59:S-69 in the brain, pathogenesis and therapy in childhood 59:S-100 chronic arm, after breast cancer therapy 59:S-76 dialysis, dryness, and fluid overload 59:S-39 diuretic-resistant, in heart failure 59:S-66 diuretic therapy in CRF 59:S-33 59:S-36 diuretic therapy in hypertensives diuretics, adverse reactions of 59:S-16 diuretics and renal transport 59:S-11 59:S-1 formation, the problem of hemofiltration in severe heart failure 59:S-62 59:S-118 history of, and its management history of common salt 59:S-127 in the ICU, causes of 59:S-105 59:S-82 myxedema and hypothyroidism neonatal 59:S-97 9:S-2i in nephrotic syndrome 58:S-75 in nephrotic syndrome, intractable overview of edematous states 59:S-2 pathogenesis of formation in NS 58:S-72 plants as sources of salt 59:S-114 plasma cAMP and renal function 59:S-50 59:S-90 in pregnancy unusual disorder of salt and water balance 59:S-11 I VP and oxytocin as antidiuretic hormones (ahst) 949 water and Na retention in cirrhosis 59:S-43 water and Na retention in heart failure 59:S-57 Elderly CAPD outcome comparison, older/younger patients 957 (abst) 965 prerenal azotemia, clinical characteristics (abst)

renal function in

1196

11 /3-hydroxysteroid dehydrogenase type II, biopsy findings in renal disease (abst) Embryogenesis

1310

adhesion receptors in development and remodeling . . . 1427 1361 PDGF as connective tissue regulator in 1309 Enalapril, perindopril, compared in DN (abst) End-stage renal disease (ESRD) 1170 advanced glycoxidation in renal failure 957 bicarbonate and salbutamol in hyperkalemia (ahst) 261 familial juvenile nephronophthisis type I 244 hypertensive nephrosclerosis in African Americans LBM from BIA, other nutritional parameters (abst). . . 955 819 linkage analysis of cytokines osteodystrophy, predialysis patients in Korea (abst) . . . 956 plasma amino acids, Koreans and Americans 954 compared (abst) 850 serum creatinine, prognostic significance VUR treatment, children, reflux nephropathy (abst). . . 1306 Endothelial cells 1124 C3 receptors, cultured rat glomerular 711 CD4O-induced chemokine production by hPTEC 58:S-22 chronic rejection, leukocyte interactions 703 complement synthesis by 27 glycated albumin modulates NO production 1245 human GMVEC, TNF-cr, verocytoxin cytotoxicity HUT1 1 expression in kidney vasa recta 138 419 hypoxia-induced modulation, IL-6 and 426 hypoxic stress proteins 1401 immune injury and TGF-3 164 PAl-I, Ang II and endothelial injury 964 proliferation and collagen IV synthesis (abst) Endothelin-1 (ET-1) activates c-Jun NH2-terminal kinase in MC 631 969 immunoreactivity in glomerular diseases (abst) rHuEPO effect, plasma proET-1 and ET-1, HD (abst). . 956 Endothelin (ET) 950 NO interactions, increased dietary salt (abst) 58:S-66 proteinuric progressive renal disease, DM 1780 renin synthesis and NO production Energy metabolism. See Tissue oxygen tensions and energy metabolism 324 Epinephrine, sources of human urinary Epithelial cells (EC) glomerular, FGF2-induced changes in PAN 301 glomerular, HB-EGF in GN models (abst) 1323 1265 glomerular, promoter activated by osteopontin regulation in cultured rat renal 1766 147 oxidized LDL, TGF-/3, fibronectin in human GEC 1986 Erythrocytes, splanachnic, hypovolemia and Erythropoiesis, immature reticulocyte count in CRF 953 (abst) Erythropoietin (EPO) detection in human liquor 416 ERBP binding to EPO RNA requires hsp70 579 502 gene expression, oxygen-dependent regulation 514 gene expression, oxygen regulated modeled 548 gene regulation, hypoxia and production, site of 393 production and antioxidant vitamins 497 492 production and reactive 02-species 483 production in HepG2 cells rHuEPO, intradialytic effects, vasoactive substances, 956 HD (abst) 956 rHuEPO, plasma proET-1 and ET-1, HD (abst) .

.

2103

Subject Index: Vol. 51

rHuEPO for anemia in 5/6 nephrectomized rat (abst). . . 945 therapy of anemia in CRF 622 413 unexpected hypoxia-dependent secretion

Escherichia coli

UTI in children, increased urinary Ca excretion (abst) .. 967 58:S-91 verotoxigenic and hemolytic uremic syndrome verotoxigenic and hemolytic uremic syndrome (abst). . . 1305 ESPRIT Study Group, morphometric analysis of 1624 mesangium Esterified renal P450-HETEs 1696 1719 Estrogen and calcium handling in ovariectomized rat. . Extracellular matrix (ECM) antihypertensive therapy in UNX SHR 750 1321 remodeling in wound-like renal injury (ahst) Extrahepatic C6 and renal C5b-9 1788 Extrarenal manifestations of ADPKD, Nephrology Forum 2022 .

.

F 1596 Familial benign hematuria, thin GBM nephropathy 261 Familial juvenile nephronophthisis Fas 1739 glomerular injury and ICE and autoimmunity, CrmA transgenic and lpr mice 1321 (abst) Femoral vein, HD cannulation with ultrasound (abst) . . . . 951 Fibrin deposits tissue factor inhibition, crescentic GN, renal injury 1310 (abst) tissue factor pathway inhibitor, crescentic GN, T-cells 1320 (abst) tissue factor pathway inhibitor, crescentic GN (abst). . . 1313 Fibroblast growth factor (FGF) 1088 basic, p27 levels determine MC proliferation FGF-1, FGF-2 immunolocalized in embryonic rat 1308 kidney (abst) FGF-1, FGF-2 receptor expression in glomeruli (abst) . 1308 FGF-2 induces glomerular EC injury in PAN 301 1311 PAN-induced nephrosis (abst) 1729 receptors in rat glomeruli Fibroblasts cortical, paracrine growth-regulatory interactions, 1307 human kidney (abst) human peritoneal, in 3D culture 205 Fibronectin oxidative stress in HG-induced TGF-13 in MC (abst).... 967 oxidized LDL stimulates in human GEC 147 Fibrosis Ang II and L-arginine in tissue 1481 renal interstitial, age-related GS, in Milan normotensive rats 230 renal interstitial, myofibroblast and a1(III) collagen

expression

TGF-f3 in kidney, gene therapy target 5-lipoxygenase pathway, cytokine regulation of LTB4 synthesis in monocytes Flow cytometry crossmatch, lymphocytotoxic crossmatch compared, living related donors (abst) CsA, cellular proliferation during compensatory renal growth (abst) Focal segmental glomerular sclerosis (FSGS) distinctive renal ultrasound findings (abst) fibrogenic growth factors, altered expression lipoprotein oxidation in

926 1388 1520

961 965 1315 195 1151

58:S-80 minimal change nephropathy and treatment, outcome in adults (abst) 970 Fractures, bone, vitamin K and iPTH 1218 Fucosyltransferase genes, selectin ligands and leukocytes . 1418 950 Furosemide abuse, medullary nephrocalcinosis (abst) Fusidic acid, CAPD dialysate concentrations after oral 1328 administration (abst)

G Galactose a(1,3)-Gal porcine xenoantigen

1324 eliminated, xenotransplantation models (abst) 1323 expression reduced in transgenic mice (abst) 961 Gancyclovir, optimal early CMV treatment (abst) Garn, Senator Jake 1340 957 Gastric emptying time and CAPD (abst) 1322 Gastrointestinal hemorrhage post-transplant (abst) Gelatinase A as glomerular MC growth, differentiation 1397 factor Gene expression EPO, oxygen-dependent regulation, rat hepatocytes . . . . 502 in liver, role of oxygen and 402 448 VEGF and VEGF receptor, by hypoxia Gene therapy 1493 Alport syndrome 1388 TGF-j3 in kidney fibrosis Genetics. See also Hypoxia-induced gene transcription ACE gene polymorphism in childhood reflux 950 nephropathy (abst) ACE gene polymorphism in NIDDM nephropathy 946 (abst) bull terrier hereditary nephritis, models Alport 1320 syndrome (abst) 920 changing patterns of gene expression COL4A5 mutation screening method, Alport 1324 syndrome (abst) cystinuria and SLC3A1 mutation 1893 261 familial juvenile nephronophthisis type 1 1629 gene eDNA in embryonic kidney hereditary factors, type II diabetes, diabetic 1602 nephropathy 819 linkage analysis of cytokines in ESRD linkage studies in TBM disease (abst) 1320 macrophage transfer into the glomerulus 1274 PAl-i gene polymorphism, thrombotic risk post1322 transplant (abst) 964 partial cloning of rat GBM HSPG, perlecan (abst) plasminogen/plasmin system gene deficiencies, GN 1324 (abst) 1938 polymorphism of IL-I receptor antagonist gene 1265 promoter activated by glomerular epithelium 1418 selectin ligands, leukocytes and Fuc-TVII 222 susceptibility to anti-GBM disease thrombosis post-transplant, determinants of (abst) . . . 1325 in the vasculature, role of oxygen 438 WT1 gene mutation in Denys-Drash syndrome (abst). .. 949 Gentamicin, ciprofioxacin, compared in acute 1316 pyelonephritis (abst) Giebisch, Gerhard 2046, 2052 Gitelman's syndrome, renal K wasting, Mg repletion 948 (ahst) Glomerular basement membrane (GBM) 1596 family history in thin GBM nephropathy 222 genetic susceptibility to anti-GBM disease 964 partial cloning, HSPG, perlecan (abst) 970 TGBM disease, clinicopathology (abst) .

2104

Subject Index: Vol. 51

TGBM disease without IgA deposits, children (abst) . . . 969 Glomerular capillary growth, puromycin 1311 aminonucleoside, rats (abst) Glomerular cells

apoptosis induced in rat MC by anti-Thy-i antibodies... 173 1124 endothelial, C3 receptors, rat 1323 epithelial, HB-EGF in GN models (abst) 1245 human GMVEC, TNF-a, verocytoxin cytotoxicity 1447 mesangial, adhesion molecules in 1022 mesangial, lysophosphatidic acid dual effect 1624 mesangial, morphometric analysis of Glomerular disease 969 ET-1 immunoreactivity in (abst) 58:S-62 human, molecular biology of 57 mechanical strain in diabetic nephropathy Glomerular filtration rate (GFR) 1341 renal cell injury, nature of renal function stability, short-term ant ihypertensives. . . . 793 Glomerular function 1053 high permeability of bikunin lipoprotein metabolism, antioxidants in DM (abst) . . . . 1305 826 sickle cell anemia and Glomerular injury 1739 agonistic anti-Fas antibodies in apoptosis ho pp6Oc-src modulates MC phenotype 1388 transforming growth factor-13 and Glomerulonephritis (GN) anti-GBM, anti-IFNy inhibits crescent formation and 1319 cutaneous DTH (abst) anti-Thy-I nephritis, concurrent expression, TGF-/31 967 and PDGF 13, mice (abst) 770 anti-Thy antibody-induced, chemokines and antibody independent, crescent formation in jx chain 1319 deficient mice (abst) 94 crescent formation, Thi cells direct in mice 672 crescentic, antibody independent crescentic, fibrin dependent, T-cells, TFPT changes 1320 (abst)

crescentic, IL-b treatment in rats

1809

crescentic, SK&F105685 suppresses cutaneous DTH, 1325 rats (abst) 1310 crescentic, tissue factor inhibition (abst) crescentic, tissue factor pathway inhibitor, fibrin 1313 deposits (abst) 1325 crescentic, TNF-a, IL-i blocking, rats (abst) cryoglobulinemic, pathogenetic role of MCP-1 153 694 Egr-i and MC proliferation 195 fibrogenic growth factors, altered expression HB-EGF in models, glomerular BC expression (abst). . 1323 immune complex, leukocyte migration, adhesion 1469 receptors 646 immunologic determinants of susceptibility isolated C3 mesangial proliferative, CRF progression 946 (abst) 270 membranoproliferative, IgG subclasses in 970 membranous, children, clinical studies (abst) 970 membranous, idiopathic, outcome (abst) membranous, idiopathic MPGN, clinicopathology 970 (abst) plasminogen/plasmin system gene deficiencies in mice 1324 (abst) resolution phase of acute, lipoxins and leukocytes. . . 58:S-56 Thi cells direct crescent formation, mice 94 1306 tubulointerstitial processes (abst) Glomerulosclerosis (GS)

age-related, renal findings in normotensive Milan rats . . 230 1315 FSGS, distinctive renal ultrasound findings (abst) FSGS, fibrogenic growth factors, altered expression . . . 195 1151 FSGS, lipoprotein oxidation in 58:S-80 FSGS, minimal change nephropathy and 970 FSGS, treatment, outcome in adults (abst) 147 oxidized LDL, TGF-f3, fibronectin in human GEC Glomerulus 1500 cyclic ADP-ribose metabolism in 1729 FGF receptors in rat 301 FGF2 induces EC injury in PAN 1274 genetically engineered macrophages, transfer of 1059 Thi, cytotoxic cells, T-cells in Heymann nephritis Glucose 947 control in progression of DN (abst) degradation, reactive chemical species, PD dialysate 1330 with thiol (abst) 1797 high, MC actin disassembly in 1222 metabolism, low protein diet in uremia PAT-i gene polymorphism, thrombotic risk post1322 transplant (abst) 860 pyruvate dialysate and PD toxicity Glycated albumin modulates NO production, endothelial .

27

cells

Granuloma, schistosome-induced, hepatic fibrosis and 1370

cytokines Growth factors. See also Hypoxia-induced growth factor expression

1729 FGF receptors in rat FGFs immunolocalized in embryonic rat kidney (abst) . 1308 195 fibrogenic, altered expression in GN HB-EGF expression, 5/6 nephrectomy model (abst) . . . 1319 HB-EGF in GN models, glomerular EC expression 1323 (abst) 1774 HB-EGF in normal rat kidneys 205 human peritoneal fibroblast in 3D culture 1313 IL-b in rat mesangial cells (abst) 819 linkage analysis of cytokines in ESRD 1970 modulated by GH in children with CRF VEGF and hypoxia 448, 560, 575 Growth hormone (GH) 216 chronic metabolic acidosis, IGF-1 1970 growth factors in children with CRF 58:S-102 growth retardation and acidosis 58:S-106 IGF-axis, derangements in CRF 58:S-114 long-term rhGH in children with CR1 1855 Growth retardation, rat renal cortex, pyelonephritis

H

H -ATPase

absence on biopsy, distal renal tubular acidosis (abst). . . 948 AEI anion exchanger regulation in acidosis/alkalosis . . . 125

H-K-ATPase

a2 subunit gene in renal medulla, with hypokalemia 949 (abst) colonic overexpression, ischemic-reperfusion injury. . . 1106 728 H202 myoglobin cytotoxicity in PT cells 2056, 2060 Habib, Renée Hamburger Award 2056, 2060, 2062 Hantavirus 964 genetic diversity, HFRS and (abst) 963 serologic diagnosis in HFRS (abst) Heart failure diuretic-resistant edema in 59:S-66 hemofiltration in severe 59:S-62 .

Subject Index: Vol. 51

Na and water retention in

59:S-57

Heat shock protein 70 (HSP), ERBP binding to EPO

RNA 579 1596 Hematuria, familial benign, thin GBM nephropathy Heme proteins. See Erythropoietin; Ion channels and heme proteins as oxygen sensors Hemodialysis. See also Vascular access 317 la(OH)-vitamin D2 suppresses PTH in SHPTH basal serum biochemical markers of survival (abst) 956 953 blood acetate level changes (abst) 2018 blood transfusion during heparin-free BP variability in ESRD 1863 catheter-related sepsis, antibiotic therapy without catheter removal (abst) 945 chronic, dryness and fluid overload 59:S-39 1317 CVVHD, ARF after arsine gas exposure (abst) heparin, LMWH compared to unfractionated (abst). . . . 953 1326 heparin-fraxiparine (CY216) (abst) 952 heparin-induced thrombocytopenia (abst) 348 hepatitis G virus infection histological 132m amyloidosis in

1928

1212 hypoalbuminemia and low diastolic BP 1326 IDPN in malnourished patients (abst) 955 iv. calcitriol effect, SHPTH and BMD (abst) Kt/V, creatinine clearance as indices of nutrition (abst) . 954 LBM derived from BIA, other nutritional parameters 955 (abst) 1312 LDL oxidative status (abst) 1327 LDL subfraction profiles (abst) 1980 leptin clearance in renal failure 953 maintenance and acid-base imbalance (abst) 953 membranes, heparin pre-rinsed hemophan (abst) membranes, NO release in peripheral blood during . . . . 294 1316 MRI findings in chronic shoulder pain (abst) 1326 multinational study of (abst) 1329 Na modeling, ultrafiltration profiling (abst) 294 NO release in peripheral blood during 956 rHuEPO effect, plasma proET-1 and ET-1 (abst) rHuEPO intradialytic effects, lipid peroxidation (abst) . . 956 958 serum Lp(a), apolipoprotein(A) (abst) 1986 splanachnic erythrocytes and hypovolemia TBW estimation 1578 1326 urea reduction ratios, albumin levels (abst) Hemofiltration 1326 CVVH in critically ill children (abst) in severe heart failure 59:S-62 Hemolytic uremic syndrome (HUS) 1317 plasmapheresis in postpartum (abst) 58:S-97 thrombotic microangiopathy 1245 verotoxin, TNF-a, effects on GMVEC 58:S-91 verotoxin-producing E. coli and verotoxin-producing E. coli and (abst) 1305 1317 Hemorheological investigations in PKD (abst) Hemorrhagic fever with renal syndrome (HFRS) diagnostic method using recombinant nucleocapsid 963 proteins (abst) 964 genetic diversity of Hantavirus (abst) Henoch-Schönlein nephritis, IL-I receptor antagonist 1938 gene polymorphism Heparan sulfate proteoglycans (HSPGs), perlecan, 964 partial cloning of rat GBM (abst) Heparin -free HD, blood transfusion during 2018 952 -induced thrombocytopenia in HD patients (abst) 953 LMWH compared to unfractionated, HD (abst)

2105

952 lupus, and ACA in vascular access occlusion (abst) pre-rinsed hemophan membrane, routine 953 heparinization (abst) Heparin-binding epidermal growth-like growth factor (HB-EGF) distribution and mRNA in normal rat kidneys 1774 1319 expression in 5/6 nephrectomy model (abst) glomerular EC expression, in GN models (abst) 1323 Heparin-dependent anti-platelet antibodies in HIT (abst) . 952 Heparin-fraxiparine (CY216) dose, safety, dialysis 1326 performance in HD (abst) Hepatic fibrosis, cytokines and schistosome-induced 1370 granuloma 1933 Hepatic lipase deficiency in NS Hepatitis C virus (HCV) in dialysis and transplantation. . . 981 348 Hepatitis G virus (HGV) in hemodialysis patients 483 HepG2 cells, oxygen sensing pathway 288 Herbal nephropathy, NEP monitors PT injury Heredity. See Genetics Heymann nephritis 1325 CD8 T-cell depletion, proteinuria (abst) 1059 T-cell mediation High anion gap metabolic acidosis, urine osmolar and 949 anion gaps compared (abst) High-density lipoprotein (HDL), oxygen radicals, renin 253 release in JG cells HPLC fractions, calcium pump inhibitors in uremic 1042 plasma Human immunodeficiency virus, renal TGF-p in 1568 associated renal diseases Human leukocyte antigens (HLA) processing and 58:S-2 presentation Human T-lymphotropic virus-i (HTLV-1), renal disease, 1318 Australian Aborigines (abst) Human urea transporter (HUTI 1) expression in kidney 138 vasa recta 138 HUT11 expression in kidney vasa recta Hydrocortisone, leukocyte adhesion molecule expression 967 (abst) Hydrogen, IGF-1, apical Na-H exchange in human PTC 1323 (abst) Hydronephrosis 951 antenatal, due to UPJ obstruction (abst) 1133 decorin expression insulin and rat renal microcirculation 1507 Hydroxyeicosatetraenoic acids (HETEs), cytochrome 1696 P450-derived renal Hyperapobetalipoproteinemia, microalbuminuria, IDDM 1305 (abst) 959 Hypercalcemia, risk factors in CAPD (abst) Hypercalciuria 640 crystal inhibition in rats 1540 defective Ca reabsorption, rats 1018 thiazides correct, in hypertensive rats Hyperchloremic metabolic acidosis, Nephrology Forum... 591 1322 Hypercholesterolemia, transplantation and (abst) Hyperkalemia, concurrent bicarbonate and salbutamol, 957 acute therapy (abst) Hyperkalemic hyperchloremic metabolic acidosis, 591 Nephrology Forum Hyperlipidemia, simvastatin efficacy post-transplant 1315 (abst) Hyperosmolality, MMP9 in human peritoneal mesothelial cells 337 Hyperparathyroidism

2106

Subject Index: Vol. 5/

328 depressed Ca receptor expression in parathyroid SHPTH, iv. calcitriol effect, BMD, chronic HD (abst) . . 955 SHPTH, parathyroid Ca sensing in renal 1590 osteodystrophy SHPTH, PTH suppression by 1 a-hydroxyvitamin D2, 317 HD Hypertension arterial, renal consequences of, Nephrology Forum. . . . 1639 104 As4.1 cell line and prorenin activation 950 BNP release and body fluid balance changes (abst) 1863 BP variability in ESRD 59:S-36 diuretic therapy in 1596 family history in thin GBM nephropathy hypokalemia, adrenal tumor with dissecting aneurysm 945 (abst) isolated kidney function, DOCA-salt hypertensive rats 1307 (abst) 244 nephrosclerosis in African Americans ouabain, BNP effects in saline-loaded sheep (abst) . . . . 1308 945 polyarteritis nodosa with renal involvement (abst) 963 post-transplant (abst) pregnancy, spot urine protein-to-creatinine ratio (abst). 1306 renal amylin binding correlated with BP, rat (abst). . . . 1309 1196 renal function in the elderly 722 renal nerves and 1018 thiazides correct SHR hypercalciuria 1212 Hypoalbuminemia, low diastolic BP, chronic HD

Hypokalemia

H-K-ATPase a2 subunit gene in renal medulla 949 (abst) hypertension, adrenal tumor with dissecting aneurysm 945 (abst) ritodrine- and terbutaline-induced, in preterm labor. . . 1867

Hypophosphatemia and Mg2 uptake in mouse DCT.... 1710 Hypothalamus, posterior, renal nerves and hypertension .. 722 Hypovolemia and splanachnic erythrocytes Hypoxia

cytoprotective effects of C1 channel blockers ROS in reoxygenation, renal cell injury (abst) tyrosine phosphoiylation in Hypoxia-induced gene transcription EPO gene regulation HIF-i, structural/functional analysis of HIF-1 DNA site is cAMP-responsive HIF-1 a mRNA regulation hypoxia and tyrosine hydroxylase gene expression hypoxia in yeast oxygen and dioxin signaling oxygen-regulated genes, EPO as model PCK gene and oxygen regulation protein phosphoiylation, gene activation by hypoxia and reduced 02 tension and gene expression Hypoxia-induced growth factor expression endothelial cell properties and endothelial hypoxic stress proteins erythropoietin in human liquor in rat kidney in vivo vascular responses to hypoxia VEGF, VEGF receptor gene expression Hypoxia-induced ICAM-1 on tubular cells Hypoxia-induced mRNA stabilization ERBP binding to EPO RNA requires hsp70 hypoxic induction of VEGF regulation of TH mRNA stability

1986 1529 951 1747

548 553 564 560 536 507 567 514 542 556 527 419 426 416 444 438 448 1703 579 575 585

Hypoxia-inducible transcription factor-i (HIF-1) DNA recognition site is cAMP-responsive oxygen and dioxin signaling, mouse hepatoma cells structural/functional analysis of Hypoxia-inducible transcription factor-ia (HIF-la) mRNA regulation

564 567 553 560

I Idiopathic membranoproliferative glomerulonephritis 970 (MPGN), clinicopathology (abst) Idiopathic membranous glomerulonephritis 873 methods in research on 970 outcome, contributing factors (abst) 901 validation of a prediction model IgA nephropathy (IgAN) 1257 activated complement C3 969 aspirin plus dipyridamol and ACEi therapy (abst) 1319 binding of polymeric A-IgA in human MC(abst) 195 fibrogenic growth factors, altered expression 1938 polymorphism of IL-i receptor antagonist gene TGBM disease without glomerular deposits, in 969 children (abst) 270 IgG subclasses in MPGN, MN and lupus nephritis 187 Imidazolone modifies amyloid f32m, dialysis-related Immunology 646 determinants of susceptibility to GN HLA system, antigen processing and presentation.... 58:S-2 1327 peritoneal cavity defense mechanisms, PD (abst) Immunoreactivity of ET-i in glomerular diseases (abst). . . 969 Immunosuppression drug comparisons on cytokine mRNA, human MLC 1320 (abst) 58:S-48 rationale and mechanisms of SK&F1 05685 suppresses crescentic GN cutaneous 1325 DTH, rats (abst) 653 Indomethacin, acute ureteral obstruction Infection antibiotic therapy, I-ID catheter-related sepsis without 945 catheter removal (abst) 960 CAPD exit-site, surgical management (abst) fusidic acid concentrations in CAPD dialysate (abst). . . 1328 1327 peritoneal cavity defense mechanisms, PD (abst) 1328 sclerosing peritonitis in Australia (abst) 58:S-41 xenosis and xenotransplantation Injury, renal 653 acute ureteral obstruction 1553 Ang II and TGF-j31, post-subtotal nephrectomy 1529 cytoprotective effects of Cl- channel blockers 1388 glomerular and TGF-J3 79 IL-12 in tubular epithelium of MRL-Fas" mice 1401 immune, TGF-J3 and endothelial cells ischemia, leukocytes, cell adhesion molecules and 1463 ARF 1341 nature of renal cell injury 966 preventive effects of allopurinol, rats (abst) 1312 remipril, valsartan effects on progression (abst) 1106 reperfusion, and acid-base transporters 1487 RGD peptides as therapeutics 951 ROS in hypoxia/reoxygenation (abst) 1310 tissue factor inhibition, crescentic GN (abst) 1747 tyrosine phosphorylation in hypoxia 1321 wound-like, ECM remodeling in (abst) Insulin 1037 mechanisms of action in TAL, kinases and 1507 renal microcirculation

Subject Index: Vol. 51

Insulin-dependent diabetes mellitus (IDDM) elevated plasma total renin precedes 1309 microalbuminuria, DN (abst) hyperapobetalipoproteinemia, microalbuminuria (abst). 1305 1624 morphometric analysis of mesangium Insulin-like growth factor-i (IGF-1) 1323 apical Na-H exchange, human PTC (ahst) chronic metabolic acidosis effect on GH 216 extended use in CRF 840 58:S-106 GH-axis, derangement in CRF growth retardation and acidosis 58:S-102 811 intrarenal, changes in DM nutritional status in CAPD (abst) 960 Integrins cytoplasmic domain modulates cell proliferation 1434 1441 laminins, in tissue remodeling 1454 ligand binding and activation 1900 mesangial cell expression of a 1413 as signaling molecules, tumor therapy targets Intensive care unit (ICU), causes of edema in 59:S-105 Intercellular adhesion molecule-i (ICAM-1) hypoxia-induced, on tubular cells 1703 IL-b enhances MC expression, rats (abst) 1324 oxidized LDL and MC proliferation (abst) 967 Interleukin-1j3 converting enzyme (ICE), Fas, autoimmunity, CrmA transgenic and lpr mice (abst) . . . 1321 Interleukin-1 (IL-i) blockade in rat crescentic GN (abst) 1325 1938 receptor, polymorphism of antagonist gene Interleukin-2 (IL-2) receptor in nephrotic syndrome. . . 58:S-83 Interleukin-6 (IL-6) differential regulation of chemokines 1754 419 expression, hypoxia and endothelium LPS induced expression, growth arrested human MC 968 (abst) mediates MC proliferation, matrix production 69 Interleukin-lO (IL-lU) effect on crescentic GN in rat 1809 1313 as growth factor, rat mesangial cells (abst) MC expression of MHC class II, ICAM-1, rats (abst) . 1324 Interleukin-12 (IL-12), tubular epithelial, autoimmune MRL-Fas" mice with renal injury 79 2037 International Congress of Nephrology International Society of Nephrology (ISN) 2046 awards, presentation of Report of the Editor 1663 Report of the incoming President 2040 Report of the President 2038 Report of the President of the XIVth ICN 2037 2042 Report of the Secretary-General Report of the Treasurer 2044 Intradialytic parenteral nutrition (IDPN), malnourished 1326 HD patients (abst) Intrarenal nitric oxide monitoring 1619 Intravascular hemolysis, arsine gas exposure, CVVHD 1317 (abst) Ion channels and heme proteins as oxygen sensors chloride channels and volume regulation 477 .

cytochrome b558 and oxygen sensing EPO and oxygen signaling cascade

EPO production, vitamins, antioxidants EPO production and ROS oxygen deprivation in central neurons oxygen sensing by ion channels oxygen sensing in HepG2 cells

479 502 497 492 467 454 483

sodium nitroprusside, effects in rat CCD vascular smooth muscle responses to oxygen Ionizing radiation induces apoptosis in MC (abst)

Iron -induced toxicity of PTC, NO (abst) myoglobin cytotoxicity in PT cells Ischemia, renal leukocytes, cell adhesion molecules and ARF reperfusion injury, acid-base transporters reperfusion injury, allopurinol's preventive effects (abst)

2107 473 462 968 1323 728

1463 1106

966

J Juxtaglomerular cells, atherogenic lipoproteins, oxygen radicals, renin release

253

K Ketoacidosis, diabetic, cerebral edema after treatment of. 1237 Kidneys a-subunit of neutrophil NADPH oxidase and 5'NT in .. 479 African American Study of Kidney Disease (AASK) Trial 244 AGE binding, quantitation and receptor, diabetic rats 1314 (abst) ANP mRNA in diabetic rats 1100 1950 [Ca2],, PTH, Via, AT1 receptors in diabetes 920 changing patterns of gene expression chloride channels and volume regulation 477 esterified renal P450-HETEs 1696 FGFs immunolocalized in rat embryonic (abst) 1308 HB-EGF distribution and mRNA in normal rat 1774 human urinary epinephrine, sources of 324 HUTI I expression in medullary vasa recta 138 444 hypoxia and growth factor expression, rat intrarenal distribution of rabbit PKC-zeta 1831 isolated function in DOCA-salt hypertensive rats 1307 (abst) leptin clearance in renal failure 1980 in mitochondrial cytopathies 1000 739 ontogeny of bradykinin B2 receptors 1847 osmolyte transporters in remnant oxidant stress in experimental DM (abst) 1314 372 oxygen pressure in paracrine growth-regulatory interactions, human (abst). 1307 PDGF a-receptor, human 1140 size/weight, morphometric study of Korean adults 951 (abst) Thi effectors in human graft rejection 1876 497 vitamins, antioxidant, and EPO production Kinases ALK-5, TGF-f31, developing rat metanephros (abst). . . 1310 762 cell cyclins during renal development ET-1 activates c-Jun NH2-terminal kinase in MC 631 intrarenal distribution of rabbit PKC-zeta 1831 542 oxygen regulation and PCK gene p27 levels determine MC proliferation 1088 PKC, hypoxia, tyrosine hydroxylase gene expression.. . . 536 PKC and insulin's action in TAL 1037 PKC mediates MC actin disassembly 1797 1028 tyrosine kinase, TGF-/3 expression, stretch in MC tyrosine kinase c-src modulates MC phenotype 110 Kincaid-Smith, Priscilla 2056, 2062 Korea kidney size/weight, morphometric study of adults

(abst)

951

2108

osteodystrophy in predialysis patients (abst)

plasma amino acids, ESRD (abst)

Kurokawa, Kiyoshi

Subject Index: Vol. 51

956 954 2040

L 1481 L-arginine (L-Arg), Ang II, in tissue fibrosis 1441 Laminins, integrins, in tissue remodeling Leaf, Alexander 2046, 2049 Lean body mass (LBM) BIA, other nutritional parameters in ESRD, HD 955 (abst) creatinine generation rate 855 measurements compared in CAPD (abst) 959 1205 Left ventricular hypertrophy (LVH) post-transplant Leptin clearance in renal failure 1980 Leukemia inhibitory factor (LIF), differential regulation of chemokines 1754 Leukocytes 967 cell adhesion molecules, hydrocortisone effect (abst) cell adhesion molecules, ischemic ARF 1463 chronic rejection, endothelial interactions 58:S-22 58:S-56 lipoxins and glomerulonephritis migration in immune complex GN, adhesion receptors. 1469 860 pyruvate dialysate and PD toxicity trafficking, selectin ligands and Fuc-TVII 1418 Leukotrienes, cytokine regulation of LTB4 synthesis in 1520 monocytes 1454 Ligand-integrin interactions Lipid peroxidation increased circulating products in pre-eclampsia (abst). . 1310 rHuEPO intradialytic effects, vasoactive substances, 956 HD (abst)

Lipids

cholesterol feeding, and PAl-i in CsA nephrotoxicity. . 1818 oxidized LDL, TGF-f3, fibronectin in human GEC 147 Lipopolysaccharide (LPS), IL-6, growth arrested human 968 MC (abst) Lipoprotein atherogenic, oxygen radicals, renin release in JO cells. . . 253 hyperapobetalipoproteinemia, microalbuminuria, 1305 IDDM (abst) metabolism, antioxidants, glomerular and tubular 1305 dysfunction in DM (abst) VLDL receptor deficiency in uremia 913 Lipoprotein(a) atherosclerotic CV disease, CAPD (abst) 958 serum concentration, albumin infusion, CAPD (abst) . . . 958 serum concentration, apolipoprotein(A), CAPD, HD (abst)

958

Lipoxins, leukocyte recruitment in ON 58:S-56 Liver cr-subunit of neutrophil NADPH oxidase and 5'NT in .. 479

EPO gene expression, oxygen-dependent regulation... . 502 extrahepatic C6 and renal C5b-9 1788 hepatic fibrosis, cytokines and schistosome-induced 1370 granuloma 1933 hepatic lipase deficiency in NS oxygen, role in gene expression, carbohydrate metabolism 402 oxygen and dioxin signaling, mouse hepatoma cells 567 542 PCK gene and oxygen regulation, rat plasma cAMP and renal function, hepatorenal link. . 59:S-50 497 vitamins, antioxidant, and EPO production water and Na retention in cirrhosis 59:S-43 Loop diuretics, ACE, and renal tubular cells 36

Low birth weight, albuminuria, RF in Australian Aborigines (abst) Low density lipoprotein (LDL) CsA and lipid peroxidation enhanced uptake, nephrotic children (abst) oxidative status in HD patients (abst) oxidized, MC proliferation, ICAM-1 expression (abst) . stimulates TGF-f3, fibronectin in human GEC subfraction profiles, chronic HD and PD (abst) VLDL receptor deficiency in NS Low molecular weight heparin, compared to unfractionated, HD (abst) Lumbar spine, BMD analysis by DXA in dialysis (abst) . Lupus anticoagulant, ACA, in vascular access occlusion (ahst) Lupus nephritis clinical characteristics (abst) clinical manifestations (abst) cyclophosphamide therapy, renal survival in black Americans IgG subclasses in IL-12 in tubular epithelium of MRL-Fas1" mice mycophenolate mofetil limits renal damage prognosis (abst) Luteinizing hormone (LH) receptor inhibitors in boys with CRF Lysophosphatidic acid dual effect, glomerular MC proliferation .

1318 1608 1313

1312

. 967 147 1327 1761

953 1329

952 947 947 1188

270 79 1583

947 777 1022

M Macrophage migration inhibitory factor (MIF), rat anti-

GBM GN (abst) 1313 Macrophages 1274 genetically engineered, transfer into glomerulus MCP-1 mediates in GN 770 Magnesium renal potassium wasting in Gitelman's syndrome (abst). . 948 transport in DCT, thiazides alter 1008 1710 uptake in mouse DCT, phosphate depletion and Magnetic resonance imaging (MRI) 50 kidney morphology, diabetic/non-diabetic rats shoulder pain in chronic HD (abst) 1316 Major histocompatibility complex (MHC) class II, IL-b, 1324 MC expression, rats (abst) Matrix metalloproteinases (MMPs) artificial activation of (abst) 1312 human peritoneal mesothelial cells, hyperosmolality, TGF-f31

prostaglandin E2 stimulates MMP-2 Medullary nephrocalcinosis, long-term furosemide abuse (abst) Medullary vasa recta, HUT1 1 expression Membranes, hemodialysis heparin pre-rinsed hemophan (abst) NO release in peripheral blood during HD Membranous glomerulonephritis children, clinical studies (abst) idiopathic, outcome (abst) idiopathic MPGN, clinicopathology (abst) Membranous nephropathy, IgG subclasses in Mesangial cells (MC) actin disassembly in high glucose, PKC, polyol pathway ..

Ang II induces PAT-i apoptosis induced in rat GMC by anti-Thy-i antibodies

337 1116

950 138

953 294 970 970 970 270 1797

664 173

Subject index: Vol. 51

1319 binding of polymeric A-IgA in IgAN (abst) [Caji, Ang II and norepincphrine, diabetic rats 87 1228 cycle control by TGF-pl 631 ET-1 activates c-Jun NH2-terminal kinase 1900 expression of a integrins 1397 gelatinase A as growth, differentiation factor 1447 glomerular, adhesion molecules in 1624 glomerular, morphometric analysis of HG-induced TGF-p, oxidative stress, fibronectin 967 production (abst) human growth arrested, LPS induced IL-6 expression. . . 968 IL-6 mediates proliferation and matrix production 69 1313 IL-lU as growth factor, rats (abst) ionizing radiation, cytotoxic drugs induce apoptosis 968 (abst) MHC class II, ICAM-1 expression, IL-lU, rats (abst) . . 1324 110 ppo0c-src modulates MC phenotype 694 proliferation, Egr-1 expression 967 proliferation, LDL and ICAM-1 expression (abst) 1022 proliferation, lysophosphatidic acid dual effect 1088 proliferation, p27 levels determine 1838 proliferation, TNP-470 inhibits 1116 prostaglandin E2 stimulates MMP-2 1028 stretch-induced TGF-p expression 687 synthesize thrombomodulin, humans 946 Mesangial proliferative GN, progression to CRF (ahst) . Mesothelial cells CA125 in peritoneal effluent 888 hyperosmolality, TGF-f31, MMP9 in human peritoneal.. 337 PD solution induces apoptosis 1280 2006 permanent peritoneal MsC line 337 regulation of gelatinases in Metabolic acidosis .

AE1 regulation and H-ATPase in apparent bicarbonate space dependent on muscle mass

.

125

948 (abst) 955 correction, muscle energy metabolism, CRF (abst) diet in chronic dialysis (abst) 955 216 growth hormone/IGF-1 endocrine axis high anion gap, urine osmolar and anion gaps 949 compared (abst) 591 hyperkalemic hyperchloremic, Nephrology Forum Metabolic alkalosis, AE1 regulation and H-ATPase in. . . 125 Metabolism. See also Tissue oxygen tensions and energy metabolism 955 muscle, acidosis correction, CRF (abst) 1182 muscle, uremia and amino acid administration 381 renal, oxygen and 1309 skeletal muscle, propionyl L-caritine, CRF (abst) skeletal muscle, with calcium channel blockers (abst) . . 1306 908 Mevalonate, plasma concentrations in uremia Microalbuminuria elevated plasma total renin precedes, DN in IDDM 1309 (abst) hyperapobetalipoproteinemia as predictor in IDDM 1305 (abst) Minimal change nephropathy, FSGS and 58:S-80 Minimal change nephrotic syndrome (MCNS) 969 adult, treatment/follow-up (abst) frequently relapsing childhood, la(OH)-vitamin D3, 965 steroid-induced osteoporosis (abst) 946 relapsing, CsA-induced remission (abst) 1000 Mitochondrial cytopathies, kidneys Mitochondrial electron transport, myoglobin cytotoxicity in PT cells 728

2109

1908 Modification of Diet in Renal Disease Study Group Monocyte chemoattractant protein-i (MCP-1) 770 chemokines and GN 153 in cryoglobulinemic membranoproliferative GN 1314 signal transduction, rat PTC (abst) Monocytes 1520 cytokine regulation of LTB4 synthesis in 785 uremic serum influences scavenger receptor Mononuclear cells, antihypertensive therapy in UNX 750 SHR Morphometric analysis of mesangium, ESPRIT Study 1624 Group Mortality basal serum biochemical markers of survival, HD 956 (abst) CV screening in elderly transplant recipients (abst). . . . 1322 1212 hypoalbuminemia and blood pressure, HD 959 serum albumin as predictor in CAPD (abst) MRL-Fas" mice, tubular epithelial IL-12 up-regulated . . . . 79 mRNA differential display, changing patterns of gene 920 expression hypoxia, ERBP binding to EPO RNA requires hsp70... 579 585 hypoxia, regulation of TH mRNA stability 575 hypoxic induction of VEGF 1100 increased ANP expression, diabetic rat kidney Muscle mass, apparent bicarbonate space, metabolic acidosis 948 (abst) 955 metabolism, acidosis correction, CRF (abst) metabolism, uremia and amino acid administration. . . . 1182

Myofibroblasts

correlate with fibrotic markers, DN (abst) role in acute rejection (abst)

Myoglobin cytotoxicity

Myoglobinuric ARF, pathogenesis of Myxedema

1314 1321 728

1956 59:S-82

N

Na /H

exchanger, NHE-3 suppression, ischemic1106 reperfusion injury Na-HCO1 cotransporter, renal, cholinergic stimulation. . . 1069 Na-Pi transport, cadmium effect, rabbit renal BBM 949 vesicles (abst) NaCl absorption in TAL, insulin-stimulated 1037 Natriuresis, acute/chronic volume expansion, ANP (abst). 1307 Natriuretic peptide atrial, acute/chronic volume expansion, natriuresis 1307 (abst) atrial, mRNA in diabetic rat kidney 1100 59:S-28 atrial, physiologic role and diuretic efficacy atrial, receptors in human CCD cell line 281 950 brain, body fluid balance (abst) brain, ouabain, effects in saline-loaded sheep (abst) . . . 1308 59:S-97 Neonatal edema Nephrectomy heparin-binding EGF expression, 5/6 nephrectomy 1319 model (abst) 1847 osmolyte transporters in remnant kidney Nephritis 964 acute tubulointerstitial, apoptosis and (abst) anti-Thy-i, TGF-131, PDGF-/3 expression, mice (abst)... 967 bull terrier hereditary, as model for Alport syndrome 1320 (abst) Heymann, T-cell mediation 1059

2110

Subject Index: Vol. 51

1583 lupus, mycophenolate mofetil limits renal damage Nephrocalcinosis, medullary, furosemide abuse, adults 950 (abst) Nephrolithiasis, supersaturation and stone composition . . . 894 Nephrons 1548 alB-adrenoceptor mRNA in rat nephron segments. . 1999 calcitonin effect on calcium transport 739 segmental maturation, kinin receptors 386 TGF prevents oxygen deficiency Nephropathy. See also Diabetic nephropathy; IgA nephropathy 950 childhood reflux, ACE gene polymorphism (abst) 288 Chinese herbs, NEP monitors PT injury 873 idiopathic membranous, methods in research on idiopathic membranous, validation of a prediction 901 model 1319 IgA, binding of polymeric A-IgA (abst) 270 membranous, IgG subclasses in 58:S-80 minimal change and GSGS 301 PAN, FGF2-induced glomerular EC injury 2 progressive, pathophysiology of reflux, VUR treatment, ESRD prevention in children 1306 (abst) 1669 smoking, renal risks of 244 Nephrosclerosis, hypertensive, in African Americans Nephrosis enhanced LDL uptake, children (abst) 1313 1311 PAN-induced, basic FGF (abst) Nephrotic syndrome (NS) 1761 acquired VLDL receptor deficiency 969 adult MCNS, treatment/follow-up (abst) 868 congenital, prenatal diagnosis by DNA analysis 58:S-75 edema, intractable, management of 58:S-72, 59:S-21 edema formation, pathogenesis of 1933 hepatic lipase deficiency in interleukin-2 receptor in 58:S-83 965 pathologic types, protein C and S, CRF (abst) 946 relapsing MCNS, CsA-induced remission (abst) 58:S-85 steroid-resistant idiopathic, CsA therapy Nephrotoxicity 948 cisplatin-based chemotherapy (abst) CsA, blood lipids and PAl-I in 1818 CsA, inhibition of Ca-induced mitochondrial swelling 964 in kidney (abst) 965 CsA, verapamil, morphologic effect of (abst) 968 CsA, verapamil effect on apoptosis (abst) 950 long-term furosemide abuse, adults (abst) 467 Neurons, sensing oxygen deprivation in central Neutral endopeptidase, enzymuria in Chinese herbs 288 nephropathy Neutrophils, NADPH oxidase a-subunit, 5'NT in kidney 479 and liver Nitric oxide (NO) activation of renin synthesis and 1780 950 ET interactions, increased dietary salt (abst) impact of surgery and anesthesia on 1943 1619 intrarenal monitoring, Clark-type electrode 1323 iron-induced toxicity of PTC (abst) 1885 nitroprusside and peritoneal permeability release in peripheral blood during HD 294 sodium nitroprusside, effects in rat CCD 473 synthesis, attenuated central pressor response, CRF 954 (abst) synthesis inhibition, renal vascular reactivity, pregnant 1310 rats (abst) .

.

Nitric oxide synthase (NOS), glycated albumin modulates activity

27

Nitrogen balance, chronic metabolic acidosis, GH and 216 IGF-1 1885 Nitroprusside and peritoneal permeability Non-insulin dependent diabetes (NIDDM), ACE gene 946 polymorphism in DN (abst) Nonsteroidal anti-inflammatory drugs (NSAIDs), acute 653 ureteral obstruction 87 Norepinephrine alters [Caji in MC of diabetic rats North American Pediatric Renal Transplant Cooperative Study 58:S-69 Alport syndrome 58:S-2 antigen processing, presentation (abst) 58:S-8 CD28:B7 costimulatory interaction 58:S-1i chronic rejection and tolerance 58:S-85 CsA and steroid-resistant nephrosis 58:S-66 diet, antihypertensives and diabetes edema in NS 58:S-72, 58:S-75 58:S-106 GH/IGF-axis in CRF 58:S-102 growth retardation and acidosis 58:S-83 IL-2R in NS 58:S-48 immunosuppression 58:S-15 intrarenal gene expression, rejection 58:S-22 leukocytes, endothelium, chronic rejection 58:S-56 lipoxins, leukocytes and GN 58:S-114 long-term rhGH, children with CR1 58:S-80 MCN and FSGS 58:S-62 molecular biology, human glomerular diseases 58:S-97 thrombotic microangiopathy 58:S-51 transplantation in 21st century 58:S-91 verotoxin and HUS 58:S-28, 58:S-36 xenotransplantation 58:S-46 xenotransplantation, ethics of 58:S-41 xenotransplantation and infection, xenosis Nutritional status 855 creatinine generation rate and LBM 1326 IDPN in malnourished HD patients (abst) 960 IGF-1, relationship between in CAPD (abst) Kt/V, creatinine clearance compared as indices (abst). . . 954 955 LBM derived from BIA, ESRD and HD (abst) 958 peritoneal membrane transport, CAPD (abst)

0

Obstruction 653 acute ureteral obstruction 951 UPJ, antenatal hydronephrosis outcome (abst) 1754 Oncostatin M, differential regulation of chemokines la-hydroxyvitamin D2 in secondary hyperparathyroidism .. 317 I a(OH)-vitamin D3, steroid-induced osteoporosis, 965 MCNS, children (abst) 739 Ontogeny, bradykinin B2 receptors 1847 Osmolyte transporters in remnant kidney Osteodystrophy 1590 parathyroid calcium sensing 956 in predialysis patients in Korea (abst) Osteopenia 804 Ca stone risk factors, post-transplant 1329 site specific risk factors in dialysis (abst) Osteopontin 1766 regulation in cultured rat renal EC 679 renal cell release, COM crystal-stimulated Osteoporosis 1719 Ca handling in ovariectomized rat steroid-induced, frequently relapsing childhood 965 MCNS, la(OH)-vitamin D3 (abst)

Subject Index: Vol. 51

Ouabain effect in saline-loaded sheep, BNP (abst) 1308 Oxidant stress 1170 advanced glycoxidation in renal failure 1314 in kidney with experimental DM (abst) Oxygen. See Hypoxia; Ion channels and heme proteins as oxygen sensors; Tissue oxygen tensions and energy metabolism Oxygen radicals, atherogenic lipoproteins, renin release in JO cells 253 Oxytocin, vasopressin, as antidiuretic hormones in edema 949 (abst)

2111

PermCath catheters 952 children, HD (abst) 952 clinical evaluation of (abst) 1710 Phosphate depletion, Mg2 uptake in mouse DCT Phosphatidylinositol 3-kinase, mechanisms of insulin's action in TAL 1037 Phosphoenolpyruvate carboxykinase (PCK) gene and 542 oxygen regulation Plants as sources of salt 59:S-114 1317 Plasmapheresis in postpartum HUS (abst) Plasminogen activator inhibitor-I (PAl-i) 164 Ang 11 and endothelial injury 664 Ang II induces in MC P 1818 blood lipids and, in CsA nephropathy p27 levels determine MC proliferation 1088 gene polymorphism, thrombotic risk post-transplant 31P-NMR spectroscopy, muscle energy metabolism, 1322 (abst) 955 metabolic acidosis, CRF (abst) Plasminogen/plasmin system gene deficiencies in GN Papillaiy thyroid carcinoma with polyarteritis nodosa 1324 (abst) 946 Platelet-derived (abst) growth factor-/3 (PDGF-/3), with TGFParacrine growth-regulatory interactions, PTC and 967 131, murine anti-Thy-i nephritis (abst) 1307 cortical fibroblasts, normal human kidney (abst) Platelet-derived growth factor-a (PDGF-a) receptor, in 966 Paraquat poisoning (abst) 1140 human kidney Parathyroid glands, depressed Ca receptor with Platelet-derived growth factor (PDGF) 328 hyperparathyroidism connective tissue regulator in embryogenesis, Parathyroid hormone (PTH) 1361 pathogenesis 1218 bone fractures, vitamin K and iPTH 1088 p27 levels determine MC proliferation 1950 [Ca21, PTC, Via, ATI receptors in diabetes Platelets 1590 calcium sensing in renal osteodystrophy anti-platelet antibodies, heparin-induced suppression by 1 a-hydroxyvitarnin D7, HD with 952 thrombocytopenia (abst) 317 SHPTH 834 reticulated, in dialysis patients Parathyroidectomy, rapid BMD changes in axial skeleton Podocytes 1308 (abst) age-related OS, interstitial fibrosis in Milan Parenteral nutrition, in malnourished HD patients (abst). 1326 230 normotensive rats Pediatrics. See Children FGF2 induces glomerular EC injury in PAN 301 Pentosidine clearance in RRT 880 966 Poisoning, paraquat (abst) Peracetic acid dialyzer re-use program, evaluation of Polyarteritis nodosa 1330 (abst) 945 hypertension of renal involvement (abst) Percutaneous kidney biopsy, Bioply gun, needle gauges . . 946 overlap type with papillary thyroid carcinoma (abst). . 1316 compared (ahst) Polycystic kidney disease (P1(D) Percutaneous transluminal renal angioplasty patency, ADPKD, extrarenal manifestations, Nephrology 798 sonographic study 2022 Forum 1309 Perindopril, enalapril, compared in DN (abst) ADPKD, sex hormones and fluid secretion in MDCK Peritoneal dialysis (PD). See also Continuous ambulatory 1535 cells peritoneal dialysis (CAPD) azotemia and extrarenal manifestations 1160 CA125 in effluent 888 353 complications of, Nephrology Forum creatinine generation rate and LBM 855 1317 hemorheological investigations (abst) 1327 host defense mechanisms, peritoneal cavity (abst) 1613 microtubule active taxanes inhibit human peritoneal fibroblast in 3D culture 205 sex hormones and fluid secretion in MDCK cells 1535 hyperosmolality, TGF-pl, MMP9 in human 1797 mesothelial cells 337 Polyol pathway mediates MC actin disassembly 1327 Posterior hypothalamus, renal nerves and hypertension . . . 722 LDL subfraction profiles (abst) 59:S-76 860 Postmastectomy edema pyruvate dialysate and PD toxicity 1280 Postural changes, volume estimation from bioimpedance solutions induce mesothelial cell apoptosis 1078 spectroscopy solutions with thiol compounds, glucose degradation 1330 Potassium (abst) depletion, ritodrine- and terbutaline-induced, in 1328 surgical aspects of PD (CAPD) access (abst) 1867 preterm labor Tenckhoff catheter malfunction, fluoroscopic 1008 depletion alters Mg2 transport in DCT 957 repositioning (abst) Peritoneal membrane renal wasting in Gitelrnan's syndrome, Mg repletion 948 1885 (abst) permeability and nitroprusside 958 Potassium channels, sensing oxygen deprivation in transport, nutritional status in CAPD (abst) 467 central neurons Peritonitis 110 960 pp60c-src modulates MC phenotype CAPD connector systems compared (abst) 1310 fusidic acid concentrations in CAPD dialysate (abst)... 1328 Pre-eclampsia, lipid peroxidation products (abst) 1327 Pregnancy peritoneal cavity defense mechanisms, PD (abst) 1328 59:S-90 edema in sclerosing, in Australia (abst)

2112

Subject index: Vol. 51

hypertensive, spot urine protein-to-creatinine ratio (abst) lipid peroxidation products, pre-eclampsia (abst) NO synthesis inhibition, renal vascular reactivity, rats (abst) outcome of children born to mothers post-transplant (abst) plasmapheresis in postpartum HUS (abst) ritodrine- and terbutaline-induced hypokalemia Prenatal diagnosis, congenital NS, Finnish type Preterm labor, ritodrine- and terbutaline-induced hypokalemia in Promoter activated by glomerular epithelium Propioriyl L-caritine, skeletal muscle metabolism, CRF

1306 1310

(abst) 1310 1322 1317 1867 868 1867 1265 1309

(abst)

Prorenin activation, prohormone convertases, mouse As4.1 cell line Prostaglandin E2 stimulates MMP-2 in rat MC Protein. See also Ion channels and heme proteins as oxygen sensors dietary, glucose metabolism in uremia endothelial hypoxic stress ERBP binding to EPO RNA requires hsp70 phosphorylation, gene activation by hypoxia and vascular morphogenesis regulated by SPARC Protein C and protein S, NS pathologic types, CRF (abst) Protein kinase C (PKC) hypoxia and tyrosine hydroxylase gene expression intrarcnal distribution of rabbit PKC-zeta mechanisms of insulin's action in TAL mediates MC actin disassembly Proteinuria CD8 T-cell depletion, Heymann nephritis (abst) spot urine protein-to-creatinine ratio, hypertensive pregnancy (abst) Proximal tubule cells (PTC) CD4O-induced chemokine production by hPTEC IGF-1 stimulates apical Na-H exchange, human (abst) . MCP-l unique signal transduction, rats (abst) myoglobin cytotoxicity

NO role in iron-induced toxicity (abst) paracrine growth-regulatory interactions, normal human kidney (abst) transport characteristics, human (abst) Proximal tubules carbachol and renal Na-HCO3 cotransporter cytoprotective effects of C1 channel blockers NEP in Chinese herbs nephropathy plasma cAMP and renal function reduced renal perfusion pressure, acute volume

provokes growth retardation, infant rat renal cortex . . . 1855 860 Pyruvate effect, dialysate and PD toxicity Pyuria, isolated, clinical significance post-transplant

104 1116

1222 426 579 556 1383

965 536 1831

1037 1797 1325

1306 711 1323

1314 728 1323 1307 1306 1069 1529 288

59:S-50

expansion Pseudechis australis snake venom causes renal lesions in rhabdomyolysis Pulmonary vasoconstriction, hypoxic Puromycin aminonucleoside (PAN), glomerular capillary growth, rats (abst) Puromycin aminonucleoside (PAN) nephrosis basic FGF (abst) FGF2-induced glomerular EC injury Pyelonephritis acute, DMSA renal scan in adults (abst) acute, gentamicin, ciprofloxacin compared (abst) acute uncomplicated in young men (abst) associated with ARF, clinical characteristics (abst)

44 1956

462 1311 1311 301

1319 1316 1316 966

963

R 968 Radiation, ionizing, induces apoptosis in MC (abst) Radiocontrast media effects in acute ureteral obstruction. . 653 1312 Ramipril, progression of renal damage, rats (abst) Reactive oxygen species (ROS) atherogenic lipoproteins, renin release in JG cells 253 492 erythropoietin production and 951 hypoxia/reoxygenation renal injury (abst) Recombinant human erythropoietin (rHuEPO) 945 anemia in 5/6 nephrectomized rat (abst) intradialytic effects, vasoactive substances, HD (abst) . . . 956 956 plasma proET-1 and ET-1, HD (abst) Red blood cells (RBC), calcium pump inhibitors in 1042 uremic plasma Reflux nephropathy 950 ACE gene polymorphism, children (abst)

VUR treatment, ESRD prevention in children (abst).. 1306

Rejection 962 acute, apoptosis role, clinicopathology (abst) 1289 acute allograft, Nephrology Forum adhesion molecules and 1476 CD28:B7 costimulatory interaction, alloimmune 58:S-8 responses chronic, and tolerance 58:S-11 58:S-36 hyperacute, pig xenografts 58:S-28 hyperacute, xenotransplantation 58:S-15 intrarenal gene expression during 58:S-22 leukocyte-endothelial interactions 1321 myofibroblast role in (abst) Thi effectors in human kidney graft 1876 798 Renal artery stenosis, patency of renal angioplasty Renal biopsy. See Biopsy, renal Renal cancer, von Hippel-Lindau disease and 16 Renal cells injury, nature of 1341 679 osteopontin release, COM crystal-stimulated Renal cortex AE1 and H-ATPase in acidosis/alkalosis 125 1855 pyelonephritis provokes growth retardation, rats Renal cysts, von Hippel-Lindau disease and 16 Renal development ALK-5, TGF-/31, developing rat metanephros (abst)... 1310 967 apoptosis, developing renal corpuscles, rat (abst) 762 cell cyclins during 920 changing patterns of gene expression 1629 gene cDNA in embryonic kidney kinin receptors and 739 Renal disease. See also End-stage renal disease (ESRD) 1310 11/3HSG2 findings on biopsy (abst) African American Study of Kidney Disease (AASK) Trial 244 chemokines and 610 1318 HTLV-1 infection, Australian Aborigines (abst) 1318 incidence, Australian Aborigines (abst) low birth weight, albuminuria, Australian Aborigines 1318 (abst) morphologic correlates, Australian Aborigines (abst) . . 1318 945 polyarteritis nodosa, hypertension (abst) 1908 progression, predictors of, diet modification and progressive, age-related GS, interstitial fibrosis in Milan normotensive rats 230

Subject Index: Vol. 51

progressive, pathophysiology of progressive, proteinuric, renal ET risks of smoking TGF-p in HIV-associated

2 58:S-66 1669 1568

Renal distal tubular acidosis, H-ATPase absent on biopsy (abst) Renal DMSA scans in adults with acute pyelonephritis (abst) Renal failure. See also Acute renal failure (ARF); Chronic renal failure (CRF)

1319

.

arterial function in CRF 1678 insulin renal microcirculation 1507 plasma cAMP and renal function 59:S-50 Renal injury. See Injury, renal Renal interstitial fibrosis age-related GS, in Milan normotensive rats 230 926 myofibroblast and a1 (III) collagen expression 722 Renal nerves, hypertension and Renal perfusion pressure, reduced, intraluminal Ang II and 44 Renal replacement therapy (RRT), pentosidine clearance 880 Renal vasculature, reactivity, NOSi, pregnant rats (abst) . 1310 Renin elevated plasma total, microalbuminuria, DN in 1309 IDDM (abst) secretion and NO/endothelin balance 1780 Renin-angiotensin system (RAS) 164 Ang II, PAT-i and endothelial injury 1553 Ang II and TGF-131, post-subtotal nephrectomy prorenin activation and As4.1 cell line 104 834 Reticulated platelets in dialysis patients Reticulocytes, immature as indicator of erythropoiesis in 953 CRF (abst) Retinoblastoma protein phosphorylation, MC cycle control by TGF-f31

Rhabdomyolysis ARF, myoglobin cytotoxicity

966 1956 2046 1867

948

1315 calciphylaxis in (abst) 261 familial juvenile nephronophthisis type 1 1596 family history in thin GBM nephropathy fingernail creatinine concentration as marker (abst) . . 1317 leptin clearance in 1980 low birth weight, albuminuria, Australian Aborigines 1318 (abst) 1316 outcome (abst) Renal function 1639 arterial hypertension and, Nephrology Forum azotemia, extrarenal manifestations in PKD rats 1160 calcium handling in ovariectomized rat 1719 1305 children, one-year after UTI (abst) 962 chronic dysfunction in transplant recipients (abst) diuretics, mechanism of action 59:S-11 in the elderly 1196 esterified renal P450-HETEs 1696 1307 isolated, in DOCA-salt hypertensive rats (abst) 381 metabolism, oxygen and plasma cAMP and 59:S-50 stability, GFR and short-term antihypertensives 793 Renal hemodynamics abnormalities in DN measured by duplex Doppler 1920 sonography 119 ACE gene polymorphism, early IDDM acute ureteral obstruction 653

RGD peptides as therapeutics in acute renal injury

ARF with building collapse (abst) renal lesions caused by Pseudechis australis snake venom Richards Award Ritodrine-induced hypokalemia in preterm labor

2113

1228 1487

728

S

Salbutamol, bicarbonate, acute therapy of hyperkalemia 957 (abst) Salt 950 dietary, NO and ET system interactions (abst) 59:S-127 history of common plants as sources of 59:S-114 unusual disorder of salt and water balance 59:S-111 Sandimmun Soft Gelatin Capsule and Sandimmun 960 Neoral compared (abst) Scavenger receptor, uremic serum influences 785 Schistosome-induced granuloma, fibrosis, cytokines and.. 1370 Schrier, Robert W 2038 1328 Sclerosing peritonitis in Australia (abst) Screening 1324 COL4A5 mutation, Alport syndrome (abst) 1322 CV disease, elderly transplant recipients (abst) 920 DNA library, changing patterns of gene expression risk factors of ESRD, serum creatinine 850 Secondary hyperparathyroidism (SHPTH) iv. calcitriol effect, BMD, chronic HD (abst) 955 1590 parathyroid Ca sensing in renal osteodystrophy 317 PTH suppression by la-hydroxyvitamin D2, HD Secreted protein acidic and rich in cysteine (SPARC) 1383 regulation of vascular morphogenesis by tissue distribution, TGF-f31, rat subtotal nephrectomy 1312 (abst) 1418 Selectin ligands, leukocytes and Fuc-TVII Sepsis. See Infection Sex hormones, fluid secretion in MDCK cells, PKD and. . 1535 1316 Shoulder pain, MRI findings in chronic HD (abst) Shwartzman reaction, CAM expression in rabbit (abst) ... 949 Sickle cell anemia, glomerular capillary wall function 826 1315 Simvastatin, hyperlipidemia, post-transplant (abst) Skeletal muscle 1309 metabolism, propionyl L-carnitine, CRF (abst) 1306 metabolism with calcium channel blockers (abst) SK&F105685 suppresses crescentic GN, cutaneous DTH, 1325 rats (abst) 1893 SLC3AI mutation and cystinuria Smoking, renal risks of 1669 Snake venom causes renal lesions in rhabdomyolysis . . . . 1956 Sodium IGF-1, apical Na-H exchange in human PTC (abst) ... 1323 loading, Ang II synthesis/metabolism changes (abst). . . 1309 1329 modeling, ultrafiltration profiling, HD (abst) salt and water balance, unusual disorder of 59:S-111 water and Na retention in cirrhosis 59:S-43 water and Na retention in heart failure 59:S-57 Sodium nitroprusside effects in rat CCD 473 Solid state environment, embryonic development, tissue 1427 remodeling 1986 Splanachnic erythrocytes and hypovolemia Stenting of central venous stenoses, HD 277 Steroid-induced osteoporosis, frequently relapsing 965 childhood MCNS, 1 a(OH)-vitamin D3 (abst) 58:S-85 Steroid-resistant idiopathic NS, CsA therapy Stones, renal. See Calculi 426 Stress proteins, endothelial hypoxic

2114

Subject Index: Vol. 5]

Supersaturation, urine 804 Ca stone risk factors, post-transplant 640 crystal inhibition in hypercalciuric rats 894 stone composition and Surgery 1943 anesthesia and nitric oxide 960 exit-site infection in CAPD (abst) Systemic lupus erythematosus (SLE), Fas, ICE and autoimmunity, CrmA transgenic and lpr mice (abst) ... 1321 153 Systemic vasculitis, cryoglobulinemic GN and MCP-1 T

in brain and kidney erythropoietin production, site of liver metabolism/gene expression and oxygen renal metabolism and oxygen TGF prevents nephron oxygen deficiency unexpected erythropoietin secretion, hypoxiadependent Tissue remodeling adhesion receptors in development and integrins and laminins in Total body weight estimation in HD patients Transforming growth factor-13 (TGF-13)

372 393 402 381 386

413 1427 1441 1578

HG-induced, oxidative stress, FN production in MC 967 (abst) CD8 depletion, proteinuria, Heymann nephritis 1568 in HI V-associated kidney diseases 1325 (abst) 1401 immune injury and endothelial cells cytokine regulation of LTB4 synthesis in monocytes... 1520 1355 in knockout and transgenic mouse models 94 glomerular accumulation in crescentic GN, mice 1376 latent, mechanisms of activation glomerular TFPI expression, fibrin dependent 147 oxidized LDL stimulates in glomerular EC 1320 crescentic ON (abst) 1028 stretch-induced expression in mesangial cells 1059 mediation of Heymann nephritis Transforming growth factor-j31 (TGF-f31) Taxanes inhibit polycystic kidney disease 1613 ALK-5 expression, developing rat metanephros (abst). . 1310 Tenckhoff catheters 1553 Ang II, post-subtotal nephrectomy 1328 laparoscopic insertion, CAPD, benefits of (abst) concurrent expression with PDGF-f3, murine anti-Thy957 malfunction, fluoroscopic repositioning (abst) 967 1 nephritis (abst) 1867 Terbutaline-induced hypokalemia in preterm labor increases MMP9 in human peritoneal mesothelial cells. . 337 Thi cells 1228 induces MC cycle arrest 94 direct crescent formation in GN, mice tissue distribution, SPARC, rat subtotal nephrectomy 1876 effectors in human kidney graft rejection 1312 (abst) 1059 in glomeruli, T-cells in Heymann nephritis Transplantation. See also North American Pediatric Thermodynamic equilibrium model, Ca salt urolithiasis Renal Transplant Cooperative Study; 1315 (abst) Xenotransplantation Thiazides 58:S-51 in the 21st century 1008 alter Mg2 transport in DCT 962 age/sex and graft survival rates (abst) 1018 correct SHR hypercalciuria 804 Ca stone risk factors, post-transplant Thick ascending limb (TAL), mechanisms of insulin's 962 chronic renal dysfunction in recipients (abst) 1037 action in 961 CMV detection in recipients (abst) Thin basement membrane disease CV screening in elderly recipients, mortality and (abst) 970 clinicopathological characteristics (abst) 1322 1596 family history in thin GBM nephropathy 963 diabetes mellitus after (abst) 1320 genetic linkage studies (abst) 962 donor age/sex and graft survival rates (abst) 969 without glomerular IgA deposits, children (abst) 961 donor factors, early graft function (abst) Thiol compounds, glucose degradation, PD solutions 310 early protocol biopsy, graft outcome and 1330 (abst) 962 early routine biopsies, histopathology in (abst) 1327 Thoratec arteriovenous fistulae 1325 genetic determinants of thrombosis after (abst) Thrombocytopenia, heparin-induced, prevalence in HD 981 HCV infection 952 (abst) 1322 hypercholesterolemia, retrospective review (abst) 687 Thrombomodulin synthesized by human MC 963 hypertension after (abst) Thrombosis 58:S-15 intrarenal gene expression during rejection 1325 genetic determinants of, post-transplant (abst) 963 isolated pyuria, clinical significance (abst) post-transplant risk, PAl-i gene polymorphism (abst). . 1322 961 living related, flow cytometry crossmatch (abst) vascular access, ACA and lupus anticoagulant (abst) . . . 952 . 961 living related donor, flow cytometry crossmatch (abst) . Thrombotic microangiopathy, pathogenesis and 1205 LV mass changes predicted after 58:S-97 treatment 963 nonimmunologic factors and outcome (abst) Thurau, Klaus 2052, 2054 outcome of children born to recipient mothers (abst) . . 1322 Thy-i nephritis, apoptosis induced in rat GMC by anti961 173 prognosis in Alport syndrome (abst) Thy-I antibodies Sandimmun soft gelatin capsule and Sandimmun 946 Thyroid cancer, polyarteritis nodosa and (abst) 960 2044 Neoral compared (abst) Tisher, C. Craig 1315 Tissue factor inhibition, crescentic ON, fibrin deposits, simvastatin efficacy, hyperlipidemia (abst) 1322 1310 upper GI bleeding after (abst) renal injury (abst) "What doctors don't know about kidneys," by Senator Tissue factor pathway inhibitor 1340 Jake Garn glomerular expression, T-cells, fibrin dependent 58:S-46 xenotransplantation, ethics of 1320 crescentic GN (abst) 1313 inhibition of, fibrin deposits, crescentic GN (abst) xenotransplantation, hyperacute rejection . 58:S-28, 58:S-36 58:S-41 xenotransplantation, infection and xenosis Tissue oxygen tensions and energy metabolism T-cells

.

Subject Index.' Vol. 51

932 xenotransplantation, Nephrology Forum Triglycerides, PAl-i gene polymorphism, thrombotic risk 1322 post-transplant (abst) Tubular cells absence of H-ATPase on biopsy with dRTA (abst). . . . 948 ACE and chronic diuresis 36 epithelial, IL-12 in autoimmune MRL-Fas" mice with 79 renal injury hypoxia-induced ICAM-1 on 1703 Tubular function 1308 Ca reabsorption, calcitriol, CRF (abst) lipoprotein metabolism, antioxidants in DM (abst) . ... 1305 Tubuloglomerular feedback (TGF) prevents nephron oxygen deficiency

Tubulointerstitial fibrosis decorin expression in hydronephrosis osteopontiri regulation in cultured rat renal EC Tubulointerstitial nephritis (TIN) apoptosis and (abst) apoptosis and resolution of (abst) myofibroblast and a1(III) collagen expression Tubulointerstitial processes in ON (abst) Tumor markers in CRF (abst) Tumor necrosis factor-a (TNF-a) complement synthesis by endothelial cells functional blocking in rat crescentic GN (abst) verocytoxin cytotoxicity, human OMVEC Tumor therapy and integrins Tyrosine hydroxylase gene expression, post-transcriptional regulation by oxygen

gene expression and hypoxia, Ca2 and PKC gene expression and reduced 02 tension Tyrosine kinase c-src modulates MC phenotype MC stretch-induced TGF-f3 expression mechanisms of insulin's action in TAL Tyrosine phosphorylation, DNA damage and cell death in LLC-PK hypoxia

386

1133

1766

964 1312 926 1306 954 703 1325 1245 1413

585 536 527 110 1028 1037

1747

U Ultrafiltration human peritoneal fibroblast in 3D culture 205 hyperosmolality, TGF-/31, MMP9, human peritoneal mesothelial cells 337 1329 profiling, Na modeling, maintenance HD (abst) Ultrasonography femoral vein cannulation for HD (abst) 951 renal findings, progressive focal segmental GS (abst) . . 1315 750 Uninephrectomy, antihypertensive therapy in SHR Upper gastrointestinal bleeding post-transplant (abst) . . . 1322

Urea

hemodialyzer mass transfer-area coefficients for 2013 human urea transporter (HUTII) expression in kidney vasa recta 138 Urea kinetic modeling (Kt!V) Biostat urea monitor, evaluation of (abst) 1329, 1330 estimation of equilibrated post-dialysis urea 2000 as index of nutritional status (abst) 954 two-pool model, urea distribution volume 1270 Urea reduction ratios, albumin levels, Australian HD 1326 patients (abst) Uremia amino acids and muscle metabolism 1182 calcium pump inhibitors in uremic plasma 1042

2115

glucose metabolism and low protein diet 1222 growth retardation and acidosis 58:S-102 785 influences scavenger receptor LH receptor inhibitors in boys with CRF 777 plasma mevalonate concentrations 908 913 VLDL receptor deficiency Ureteropelvic junction (UPJ) obstruction, antenatal 951 hydronephrosis outcome (abst) Urinalysis, spot urine proteiri-to-creatinine ratio, 1306 hypertensive pregnancy (abst) Urinary epinephrine, sources of human 324 Urinary excretion calcium, children with UTI (abst) 967 calcium, thiazides correct SHR hypercalciuria 1018 crystal inhibition in rats 640 NEP in Chinese herbs nephropathy 288 Urinary tract infection (UTI) 1318 children, Australian Aborigines (abst) 1305 children, renal outcome one-year after (abst) 967 increased urinary Ca excretion, children (abst) Urine ammonium (NH4), high anion gap metabolic 949 acidosis (abst) Urine osmolar and anion gaps compared, high anion gap metabolic acidosis (abst) 949 Urine supersaturation Ca stone risk factors, post-transplant 804 crystal inhibition in hypercalciuric rats 640 stone composition and 894 Urolithiasis, Ca salt, thermodynamic equilibrium model 1315 (abst) V Valsartan, progression of renal damage, rats (abst) Vascular access AVF closure, anaerobic threshold, cardiac output (abst) catheter-related sepsis, antibiotic therapy without catheter removal (abst) femoral vein cannulation with ultrasound (abst) laparoscopic Tenckhoff catheter insertion, CAPD (abst) malfunctioning Tenckhoff, fluoroscopic repositioning

1312 1321

945 951

1328

957 (abst) 952 occlusion, ACA and lupus anticoagulant (abst) 952 PermCath catheters, children (abst) PermCath catheters, clinical evaluation (abst) 952 stenting of central venous stenoses, HD 277 1328 surgical aspects of PD (CAPD) access (abst) Thoratec arteriovenous fistulae 1327 Vascular endothelial growth factor (VEGF) 448, 560 hypoxia and gene expression 575 hypoxic induction 1383 Vascular morphogenesis regulated by SPARC 438 Vascular responses to hypoxia Vascular smooth muscle responses to oxygen tension 462 changes Vasoactive substances, rHuEPO intradialytic effects, lipid 956 peroxidation, HD (abst) Vasopressin, oxytocin, as antidiuretic hormones in edema 949 (abst) Verapamil 968 apoptosis in CsA nephrotoxicity (abst) 965 morphologic effect on CsA nephrotoxicity (abst) Verotoxin 58:S-91 hemolytic uremic syndrome

2116

Subject Index: Vol. 51

1305 hemolytic uremic syndrome (abst) 1245 TNF-a, GMVEC cytotoxicity Very low density lipoprotein (VLDL) 1761 receptor deficiency in NS 913 receptor deficiency in uremia Vesicoureteric reflux (VUR), reflux nephropathy, ESRD 1306 in children (abst) Vitamin D 317 lcr(OH)-vitamin D2 in SHPTH la(OH)-vitamin D3, steroid-induced osteoporosis, 965 MCNS, children (abst) 1218 Vitamin K, bone fractures and iPTH 497 Vitamins, antioxidant, and EPO production 1900 Vitronectin, MC expression of cc, integrins Volume expansion 44 acute, intraluminal Ang II and 1307 acute/chronic, natriuresis, ANP (abst) Volume regulation 477 chloride channels and 59:S-39 dialysis, dryness, and fluid overload estimation from bioimpedance spectroscopy, postural 1078 changes and von Hippel-Lindau disease 16 renal cysts, renal cancer and

w Water balance

brain natriuretic peptide release, hypertension (abst) . . . 950 59:S-111 disorder of, salt, edema and 59:S-43 Na and water retention in cirrhosis 59:S-57 Na and water retention in heart failure VP and oxytocin as antidiuretic hormones in edema 949 (abst) 2042 Weening, Jan J 949 WT1 gene mutation in Denys-Drash syndrome (abst)

x Xenoantigen

porcine Gala(1,3) Gal, reduced in transgenic mice (abst) porcine Gala(1,3) Gal eliminated (abst) Xenotransplantation Gala(1,3) Gal eliminated in models (abst) hyperacute rejection hyperacute rejection, pig to primate infectious risks, xenosis past, present and future of, Nephrology Forum social/religious/ethical/political issues xenosis and Y

tumor suppressor gene, hypoxic induction of VEGF.... 575 von Willebrand factor, MC expression of cc, integrins.... 1900 Yeast (Saccharomyces cerevisiae), hypoxia in

1323 1324 1324 58:S-28 58:S-36 58:S-41 932 58:S-46 58:S-41

507